COVID-19 and hyperammonemia: Potential interplay between liver and brain dysfunctions

Bobermin LD, Quincozes-Santos A.

Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection

Mendizabal M, Ridruejo E, Piñero F, Anders M, Padilla M, Toro LG, Torre A, Montes P, Urzúa A, Ballerga EG, Silveyra MD, Michelato D, Díaz J, Peralta M, Pages J, García SR, Lozano IG, Macias Y, Cocozzella D, Chavez-Tapia N, Tagle M, Dominguez A, Varón A, Pozo EV, Tijera FH, Bustios C, Conte D, Escajadillo N, Gómez AJ, Tenorio L, Barradas MC, Schinoni MI, Bessone F, Contreras F, Nazal L, Sanchez A, García M, Brutti J, Cabrera MC, Miranda-Zazueta G, Rojas G, Cattaneo M, Castro-Narro G, Rubin

Non-alcoholic fatty liver disease and clinical outcomes in patients with COVID-19: A comprehensive systematic review and meta-analysis

Singh A, Hussain S, Antony B.

Characteristics and In-Hospital Outcomes of COVID-19 Patients with Abnormal Liver Biochemical Tests

Wu Y, Ma Z, Guo X, Li H, Tang Y, Meng H, Yu H, Peng C, Chu G, Wang X, Teng Y, Zhang Q, Zhu T, Wang B, Tong Z, Feng R, Zhao H, Lu H, Qi X.

Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity

Lamadrid P, Alonso-Peña M, San Segundo D, Arias-Loste M, Crespo J, Lopez-Hoyos M.

Quantifying the Evolutionary Constraints and Potential of Hepatitis C Virus NS5A Protein

Dai L, Du Y, Qi H, Huber CD, Chen D, Zhang TH, Wu NC, Wang E, Lloyd-Smith JO, Sun R.

Post-Covid-19 Cholangiopathy-A New Indication for Liver Transplantation: A Case Report

Durazo FA, Nicholas AA, Mahaffey JJ, Sova S, Evans JJ, Trivella JP, Loy V, Kim J, Zimmerman MA, Hong JC.

Management of patients with inflammatory bowel disease and outcomes during the first wave of the Covid-19 pandemic

Viola A, Giambò F, Chiappetta MF, Costantino G, Pallio S, Fries W.

Patterns and prediction of liver injury with persistent cholestasis in survivors of severe SARS-CoV-2 infection

Nayagam JS, Jeyaraj R, Mitchell T, Walder DP, Al-Agil M, Shek A, Barker R, Teo J, Maharaj R, Agarwal K, Vlachos S, Joshi D, McPhail MJ.

Risk factors and outcomes for acute-on-chronic liver failure in COVID-19: a large multi-center observational cohort study

Satapathy SK, Roth NC, Kvasnovsky C, Hirsch JS, Trindade AJ, Molmenti E, Barish M, Hirschwerk D, Da BL, Bernstein D; Northwell Health COVID-19 Research Consortium.

Videoconferencing to deliver genetics services: a systematic review of telegenetics in light of the COVID-19 pandemic

Brown EG, Watts I, Beales ER, Maudhoo A, Hayward J, Sheridan E, Rafi I.

COVID-19 Aftershocks on Alcohol-associated Liver Disease: An Early Cross-Sectional Report from the U.S. Epicenter (Manuscript HEP4-20-0491)

Rutledge SM, Schiano TD, Florman S, Im GY.

Assessing efficacy of hepatocellular carcinoma prediction scores to prioritise hepatitis B surveillance in the COVID-19 era

Sinharay R, Grant AJ, Rivett L, Blackwell R, Mells G, Gelson W.

Assessment of liver damage in patients with COVID-19 is sub-optimal: results of a survey of medical practitioners

Alventosa Mateu C, Benlloch Pérez S, Diago Madrid M.

Are nucleotide inhibitors, already used for treating hepatitis C virus infection, a potential option for the treatment of COVID-19 compared with standard of care? A literature review

Spera AM.

A High Percentage of Patients Recovered From COVID-19 but Discharged With Abnormal Liver Function Tests

Gan Q, Gong B, Sun M, Cao Z, Zheng Y, Zhang Y, Wen P, Shen Y, Hong L, Hou T, Jia Y, Li W, Li H, Xie Q.

Elevated liver enzymes, ferritin, CRP, D-dimer, and age are predictive markers of outcomes among Covid-19 African Americans and Hispanic patients

Ashktorab H, Pizuorno A, Aduli F, Laiyemo AO, Oskrochi G, Brim H.

Liver Transplantation for T2 Hepatocellular Carcinoma during the COVID-19 Pandemic: A Novel Model Balancing Individual Benefit against Healthcare Resources

Cillo U, Vitale A, Volk ML, Frigo AC, Feltracco P, Cattelan A, Brancaccio G, Feltrin G, Angeli P, Burra P, Lonardi S, Trapani S, Cardillo M.

Abnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2): A Retrospective Single-Center Study from Spain

Benedé-Ubieto R, Estévez-Vázquez O, Flores-Perojo V, Macías-Rodríguez RU, Ruiz-Margáin A, Martínez-Naves E, Regueiro JR, Ávila MA, Trautwein C, Bañares R, Bosch J, Cubero FJ, Nevzorova YA.

Liver transplantation for acute liver failure in a SARS-CoV-2PCR-positive patient

Yohanathan L, Corsini Campioli C, Mousa OY, Watt K, Friedman DZP, Shah V, Ramkissoon R, Hines AS, Kamath PS, Razonable RR, Badley AD, DeMartino ES, Joyner MJ, Graham R, Vergidis P, Simonetto DA, Sanchez W, Taner T, Heimbach JK, Beam E, Leise MD.

What do people hospitalised with COVID-19 think about their care? Results of a satisfaction survey during the first wave of COVID-19 in Liverpool

Wu MS, Watson R, Hayat F, Ratcliffe L, Beadsworth MB, McKenna M, Corney D, Plum C, Macfarlane JL, Matareed M, Butt S, Gupta S, Hine P, Defres S, Wingfield T.

Stamps deliver covid tributes

Shepherd A.

Cholestatic liver injury in COVID-19 is a rare and distinct entity and is associated with increased mortality

Da BL, Suchman K, Roth N, Rizvi A, Vincent M, Trindade AJ, Bernstein D, Satapathy SK; Northwell COVID-19 Research Consortium.

Factors associated with risk of COVID-19 contagion for endoscopy healthcare workers: A survey from the Italian society of digestive endoscopy

Mariani A, Capurso G, Marasco G, Bertani H, Crinò SF, Magarotto A, Tringali A, Pasquale L, Arcidiacono PG, Zagari RM.

Metabolic Associated Fatty Liver Disease Is Associated With an Increased Risk of Severe COVID-19: A Systematic Review With Meta-Analysis

Hegyi PJ, Váncsa S, Ocskay K, Dembrovszky F, Kiss S, Farkas N, Erőss B, Szakács Z, Hegyi P, Pár G.

COVID-19 in Children With Liver Disease

Di Giorgio A, Hartleif S, Warner S, Kelly D.

Impact of the COVID-19 pandemic on liver donation and transplantation: A review of the literature

De Carlis R, Vella I, Incarbone N, Centonze L, Buscemi V, Lauterio A, De Carlis L.

COVID-19 and the liver: an adverse outcome pathway perspective

Vinken M.

Successful treatment of positive-sense RNA virus coinfection with autoimmune hepatitis using double filtration plasmapheresis

Kamimura H, Kamimura K, Tsuchiya A, Terai S.

Liver and kidney function in patients with Covid-19 treated with remdesivir

van Laar SA, de Boer MGJ, Gombert-Handoko KB, Guchelaar HJ, Zwaveling J; LUMC-Covid-19 research group.

Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019

Gao F, Zheng KI, Yan HD, Sun QF, Pan KH, Wang TY, Chen YP, Targher G, Byrne CD, George J, Zheng MH.

Let's leverage SARS-CoV2 vaccination to screen for hepatitis C screening in Spain, in Europe, around the world

Crespo J, Lazarus JV, Iruzubieta P, García F, García-Samaniego J; Alliance for the Elimination of Viral Hepatitis in Spain.

Teaching residents how to deliver active learning during didactic lectures

Miller JL, Stephens K, Johnson PN, Medina M.

Liver Injury in COVID-19 - The culprit may not be COVID-19!

Singh A, Premkumar M, Singh V.

Progressive cholangiopathy in Covid-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered

Deltenre P, Moreno C, Trépo E.

Percutaneous microwave ablation applications for liver tumors: recommendations for COVID-19 patients

Afaghi P, Lapolla MA, Ghandi K.

The many faces of coronavirus disease 2019: COVID-19 and the liver

Almas T, Ehtesham M, Khedro T, Haadi A, Nabeel AR, Hussain S, Alsufyani R, Al-Awaid AH, Sclair S, Mansoor E.

World Tuberculosis Day 2021 Theme - 'THE CLOCK IS TICKING' - and the world is running out of time to deliver the United Nations General Assembly commitments to End TB due to the COVID-19 pandemic

Zumla A, Chakaya J, Khan M, Fatima R, Wejse C, Al-Abri S, Fox GJ, Nachega J, Kapata N, Knipper M, Orcutt M, Goscé L, Abubakar I, Nagu TJ, Mugusi F, Gordon AK, Shanmugam S, Bachmann NL, Lam C, Sintchenko V, Rudolf F, Amanullah F, Kock R, Haider N, Lipman M, King M, Maeurer M, Goletti D, Petrone L, Yaqoob A, Tiberi S, Ditiu L, Sahu S, Marais B, Petersen E.

Prospective observational study of SARS-CoV-2 infection, transmission and immunity in a cohort of households in Liverpool City Region, UK (COVID-LIV): a study protocol

Setiabudi W, Hungerford D, Subramaniam K, Vaselli NM, Shaw VE, Wilton M, Vivancos R, Aston S, Platt G, Moitt T, Jones AP, Gabbay M, Buchan I, Carrol ED, Iturriza-Gomara M, Solomon T, Greenhalf W, Naisbitt DJ, Adams ER, Cunliffe NA, Turtle L, French N; COVID-LIV Study Group.

A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation

Jeong H, Choi YM, Seo H, Kim BJ.

Risk Factors and Prognosis in Patients with COVID-19 and Liver Injury: A Retrospective Analysis

Shen JX, Zhuang ZH, Zhang QX, Huang JF, Chen GP, Fang YY, Cheng AG.

Dynamic monitoring of serum liver function indexes in patients with COVID-19

Lin H, Wu LJ, Guo SQ, Chen RL, Fan JR, Ke B, Pan ZQ.

Progressive liver injury and increased mortality risk in COVID-19 patients: A retrospective cohort study in China

Zhang SS, Dong L, Wang GM, Tian Y, Ye XF, Zhao Y, Liu ZY, Zhai JY, Zhao ZL, Wang JH, Zhang HM, Li XL, Wu CX, Yang CT, Yang LJ, Du HX, Wang H, Ge QG, Xiu DR, Shen N.

Interaction between hepatitis B virus and SARS-CoV-2 infections

Xiang TD, Zheng X.

Hepatic injury and repair patterns in fatal COVID-19: consequences for outcome subsequent to liver transplantation

Krüger M, Robson SC, Schulte Am Esch J.

Changes in digestive cancer diagnosis during the SARS-CoV-2 pandemic in Italy: A nationwide survey

Buscarini E, Benedetti A, Monica F, Pasquale L, Buttitta F, Cameletti M, Ferrari C, Ricciardiello L; FISMAD the FISMAD-ALERT Survey Group.

Could SARS-CoV-2 be associated with emphysematous gastritis?

Garrosa-Muñoz S, López-Sánchez J, González-Fernández LM, Muñoz-Bellvís L.

The effect of Chinese herbal medicine on digestive system and liver functions should not be neglected in COVID-19: an updated systematic review and meta-analysis

Shi S, Wang F, Li J, Li Y, Li W, Wu X, Kou S, Wu Y, Wang X, Pei C, Huang D, Qiu H, Wang P, Wang Z.

Model for safe elective liver resection during the SARS-CoV-2 (COVID-19) pandemic: lessons for enhanced recovery

Jitsumura M, Sethi P, Welsh FKS, Chandrakumaran K, Rees M.

A limited role of cytokine storm and fibrogenesis in COVID-19 related liver injury

Westerouen van Meeteren MJ, Van den Heuvel FM, Weijers G, Joosten LA, De Mast Q, Van de Veerdonk FL, Pickkers P, De Nooijer AH, Hoefsloot W, Drenth JP, De Korte CL, Nijveldt R, Netea MG, Tjwa ET.

Severe liver dysfunction complicating course of COVID-19 in the critically ill: multifactorial cause or direct viral effect?

Roedl K, Jarczak D, Drolz A, Wichmann D, Boenisch O, de Heer G, Burdelski C, Frings D, Sensen B, Nierhaus A, Lütgehetmann M, Kluge S, Fuhrmann V.

Acute liver and cardiac failure in multisystem inflammatory syndrome in adults after COVID-19

Vujaklija Brajković A, Zlopaša O, Gubarev Vrdoljak N, Goran T, Lovrić D, Radonic R.

New dimensions for hospital services and early detection of disease: a Review from the Lancet Commission into liver disease in the UK

Williams R, Alessi C, Alexander G, Allison M, Aspinall R, Batterham RL, Bhala N, Day N, Dhawan A, Drummond C, Ferguson J, Foster G, Gilmore I, Goldacre R, Gordon H, Henn C, Kelly D, MacGilchrist A, McCorry R, McDougall N, Mirza Z, Moriarty K, Newsome P, Pinder R, Roberts S, Rutter H, Ryder S, Samyn M, Severi K, Sheron N, Thorburn D, Verne J, Williams J, Yeoman A.

Outcome of COVID-19 in Patients with Autoimmune Hepatitis: an International Multi-Centre Study

Efe C, Dhanasekaran R, Lammert C, Ebi B, Higuera-de la Tijera F, Aloman C, Rıza Calışkan A, Peralta M, Gerussi A, Massoumi H, Catana AM, Torgutalp M, Purnak T, Rigamonti C, Gomez Aldana AJ, Khakoo N, Kacmaz H, Nazal L, Frager S, Demir N, Irak K, Ellik ZM, Balaban Y, Atay K, Eren F, Cristoferi L, Batıbay E, Urzua Á, Snijders R, Kıyıcı M, Akyıldız M, Ekin N, Carr RM, Harputoğlu M, Hatemi I, Mendizabal M, Silva M, Idilman R, Silveira M, Drenth JPH, Assis DN, Björnsson E, Boyer JL, Inver

Usage experience of remdesivir for SARS-CoV-2 infection in a patient with chronic cirrhosis of Child-Pugh class C

Umemura T, Nishikawa K, Mutoh Y, Sasano H, Kozaki K, Yamada T, Ichihara T.

Effect of Spironolactone on COVID-19 in Patients With Underlying Liver Cirrhosis: A Nationwide Case-Control Study in South Korea

Jeon D, Son M, Choi J.

Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients

Del Zompo F, De Maio F, Santopaolo F, Ricci R, Gasbarrini A, Pompili M, Ponziani FR.

Protocol to ensure continued pediatric liver transplantation service during the COVID pandemic and the encouraging outcomes

Varma S, Pandey Y, Chikkala BR, Acharya R, Verma S, B I, Sreekumar S, Das D, Dey R, Agarwal S, Gupta S.

COVID-19 and liver disease: mechanistic and clinical perspectives

Marjot T, Webb GJ, Barritt AS 4th, Moon AM, Stamataki Z, Wong VW, Barnes E.

How to deliver aerosolized medications through high flow nasal cannula safely and effectively in the era of COVID-19 and beyond: A narrative review

Ari A, Moody GB.

Fatty liver disease in obese patients with COVID-19: a tale of two pandemics?

Yeoh SL, Flaherty GT.

Capacity of Primary Care to Deliver Telehealth in the United States

Jetty A, Jabbarpour Y, Westfall M, Kamerow DB, Petterson S, Westfall JM.

Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor

Manzia TM, Gazia C, Lenci I, Angelico R, Toti L, Monaco A, Anselmo A, Baiocchi L, Grossi P, Tisone G.

Review of the current empirical literature on using videoconferencing to deliver individual psychotherapies to adults with mental health problems

Thomas N, McDonald C, de Boer K, Brand RM, Nedeljkovic M, Seabrook L.

Intravenous ketamine and progressive cholangiopathy in Covid-19 patients

Mallet V; Keta-Cov research group.

Incidence, pattern and severity of abnormal liver blood tests among hospitalised patients with SARS-COV2 (COVID-19) in South Wales

Yeoman A, Maggs DR, Gardezi SAA, Haboubi HN, Yahya MI, Yousuf F, Czajkowski MA.

Abnormal liver blood tests among hospitalised patients with SARS-CoV2 (COVID-19)

Ruiz P, Cardenas A.

Do Not Delay: Safe Operation for Pediatric Living-donor Liver Transplantation Programs in the COVID-19 Era

Yamada M, Funaki T, Shoji K, Miyairi I, Fukuda A, Sakamoto S, Imadome KI, Kasahara M.

COVID-19 and hepatitis B infection

Alqahtani SA, Buti M.

PRIMARY BILIARY CHOLANGITIS ASSOCIATED WITH SARS-COV2 INFECTION

Bartoli A, Gitto S, Sighinolfi P, Cursaro C, Andreone P.

Sonographic findings in coronavirus disease-19 associated liver damage

Spogis J, Hagen F, Thaiss WM, Hoffmann T, Malek N, Nikolaou K, Berg CP, Singer S, Bösmüller H, Kreth F, Kaufmann S.

Chronic Active Hepatitis B with COVID-19 in Pregnancy: A Case Report

Li QY, An ZY, Li C, Zu M, Chen L, Zhang JN, Zhao YY, Shen N, Ge QG.

Recommendations and Clinical Guidance for Children with Metabolic-associated Fatty Liver Disease during the COVID-19 Pandemic

Zhou YH, Rios RS, Zheng KI, Zheng MH.

A Recipient and Donor Both Have COVID-19 Disease. Should We Perform a Liver Transplant?

Tuncer A, Akbulut S, Baskiran A, Karakas EE, Baskiran DY, Carr B, Yilmaz S.

Using Telepractice to Deliver Pediatric Voice Care in a Changing World: Breaking down Challenges and Learning from Successes

Kelchner LN, Fredeking JC 2nd, Zacharias SC.

TRANSIENT SEVERE LIVER INJURY: A UNIQUE PRESENTATION OF COVID-19 DISEASE IN A PEDIATRIC PATIENT

Sgouropoulou V, Vargiami E, Kyriazi M, Papadimitriou E, Agakidis C, Zafeiriou D.

SARS-CoV-2 Infection May Present as Acute Hepatitis in Children

Brisca G, Mallamaci M, Tardini G, Martino L, Chianucci B, Ricci M, Buffoni I, Romanengo M.

A Danish population-based case series of patients with liver cirrhosis and coronavirus disease 2019

Attauabi M, Burisch J, Bendtsen F, Kimer N.

Keeping the lights on: Telehealth, testing, and 6-month outcomes for orthotopic liver transplantation during the COVID-19 pandemic

Delman AM, Turner KM, Jones CR, Vaysburg DM, Silski LS, King C, Luckett K, Safdar K, Quillin RC 3rd, Shah SA.

"Health status of children with chronic liver disease during the SARS-CoV-2 outbreak: results from a multicentre study"

Di Giorgio A, Nicastro E, Arnaboldi S, Montini O, Di Stasio F, D'Antiga L, Gaio P, Fovino LN, Cananzi M, Pinon M, Calvo PL, Camelli V.

Liver injury in the era of COVID-19

Cichoż-Lach H, Michalak A.

Reply to: Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)

López-Mendez I, Castro-Narro G.

COVID-19 hits viral hepatitis care for vulnerable populations

Samarasekera U.

Effect of COVID-19 on viral hepatitis services in Pakistan

Mustafa ZU, Kow CS, Hasan SS.

Liver injury in liver transplant patients with COVID-19: a histopathological confirmation: COVID-19 liver injury after transplantation

Ng A.

AASLD Expert Panel Consensus Statement: Vaccines to Prevent COVID-19 Infection in Patients with Liver Disease

Fix OK, Blumberg EA, Chang KM, Chu J, Chung RT, Goacher EK, Hameed B, Kaul DR, Kulik LM, Kwok RM, McGuire BM, Mulligan DC, Price JC, Reau NS, Reddy KR, Reynolds A, Rosen HR, Russo MW, Schilsky ML, Verna EC, Ward JW, Fontana RJ; AASLD COVID-19 Vaccine Working Group.

Leflunomide an immunomodulator with antineoplastic and antiviral potentials but drug-induced liver injury: A comprehensive review

Alamri RD, Elmeligy MA, Albalawi GA, Alquayr SM, Alsubhi SS, El-Ghaiesh SH.

"Chronic Viral Hepatitis C Micro-Elimination Program Using Telemedicine. The Mexican Experience"

Perez Hernandez JL, Higuera de la Tijera MF, Arce Salinas CA.

COVID-19 and the liver: The chicken or the egg dilemma

Ampuero J.

Erratum for: Management of Hepatocellular Carcinoma during the COVID-19 Pandemic - São Paulo Clínicas Liver Cancer Group Multidisciplinary Consensus Statement

Letter: liver involvement and mortality in COVID-19-the role of anti-viral therapy should be considered

Boglione L, Rostagno R, Poletti F, Moglia R, Bianchi B, Esposito M, Biffi S, Borrè S.

Can COVID-19 Cause Flare-Ups of Acute Hepatitis B? An Atypical Presentation of COVID-19 with Acute Hepatitis B

Yigit Y, Haddad M, Elmoheen A, Shogaa MR, Tawel R, Mohamed YK, Salem W, Fawzy Eltawagny M.

EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients

Cornberg M, Buti M, Eberhardt CS, Grossi PA, Shouval D.

Severity of liver test abnormalities in coronavirus disease 2019 depends on comorbidities and predicts early in-hospital mortality

Satapathy SK, Kuntzen C, Qiu H, Jiang Y, Bodenheimer HC, Roth NC, Lee TP, Hirsch JS, Trindade AJ, Bernstein DE; Northwell Health COVID-19 Research Consortium.

Human antiviral B cell responses: Emerging lessons from hepatitis B and COVID-19

Burton AR, Maini MK.

Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients

Webb GJ, Moon AM, Barnes E, Barritt AS 4th, Marjot T.

A challenging liver transplantation for decompensated alcoholic liver disease after recovery from SARS-CoV-2 infection

Gambato M, Germani G, Perini B, Gringeri E, Feltracco P, Plebani M, Burra P, Russo FP.

COVID-19 in hospitalized liver transplant recipients: an early systematic review and meta-analysis

Jayant K, Reccia I, Virdis F, Pyda JS, Bachul PJ, di Sabato D, Barth RN, Fung J, Baker T, Witkowski P.

Clinical features and potential mechanism of coronavirus disease 2019-associated liver injury

Han MW, Wang M, Xu MY, Qi WP, Wang P, Xi D.

Effect of liver injury on prognosis and treatment of hospitalized patients with COVID-19 pneumonia

Ma GG, Shen YX, Wu L, Luo Z, Zhu CW, Chen SY, Yu KH, Li F.

Impact of COVID-19 Response on Hepatitis Prevention Care and Treatment: Results From Global Survey of Providers and Program Managers

Laury J, Hiebert L, Ward JW.

Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19

Campos-Murguía A, Román-Calleja BM, Toledo-Coronado IV, González-Regueiro JA, Solís-Ortega AA, Kúsulas-Delint D, Cruz-Contreras M, Cruz-Yedra N, Cubero FJ, Nevzorova YA, Martínez-Cabrera CF, Moreno-Guillén P, Lozano-Cruz OA, Chapa-Ibargüengoitia M, Gulías-Herrero A, Aguilar-Salinas CA, Ruiz-Margáin A, Macías-Rodríguez RU.

Implications of liver injury in risk-stratification and management of patients with COVID-19

Shao J, Liang Y, Li Y, Ding R, Zhu M, You W, Wang Z, Huang B, Wu M, Zhang T, Li K, Wu W, Wu L, Wang Q, Xia X, Wang S, Lu L.

Predictors for the severe coronavirus disease 2019 (COVID-19) infection in patients with underlying liver disease: a retrospective analytical study in Iran

Bahardoust M, Heiat M, Khodabandeh M, Karbasi A, Bagheri-Hosseinabadi Z, Ataee MH, Seidalian N, Babazadeh A, Agah S, Abyazi MA.

Where have all the other coeliacs gone in 2020? Road for a 2021 catch-up with missed diagnoses

Valitutti F, Troncone R, Pisano P, Ciacci C; Campania Coeliac Disease Network.

[Clinical analysis of liver chemistries in children and adolescent with 2019-nCoV infection]

Wang XS, Cai JH, Zeng M, Tian H, Chang HL, Ge YL, Li JJ, Wei ZQ, Wang JS.

Mortality is Not Increased in SARS-CoV-2 Infected Persons With Hepatitis C Virus Infection

Butt AA, Yan P, Chotani RA, Shaikh OS.

Liver injury predicts overall mortality in severe COVID-19: a prospective multicenter study in Brazil

Pozzobon FM, Perazzo H, Bozza FA, Rodrigues RS, de Mello Perez R, Chindamo MC.

The impact of coronavirus disease 2019 (COVID-19) on liver injury in China: A systematic review and meta-analysis

Zhao X, Lei Z, Gao F, Xie Q, Jang K, Gong J.

The Impact of Direct Acting Antivirals on Hepatitis C Virus Disease Burden and Associated Costs in Four European Countries

Mennini FS, Marcellusi A, Robbins Scott S, Montilla S, Craxi A, Buti M, Gheorghe L, Ryder S, Kondili LA.

Liver damage in Covid-19 patients: need for more attention

Testino G, Pellicano R.

Liver Function Status in COVID-19: An Indian Perspective

Mukherjee K, Banerjee A, Bhattacharjee D, De S, Biswas A, Garai D, Chakraborty R, Manna A.

COVID-19-associated liver injury: from bedside to bench

Li D, Ding X, Xie M, Tian D, Xia L.

Is liver involvement overestimated in COVID-19 patients? A meta-analysis

Li G, Yang Y, Gao D, Xu Y, Gu J, Liu P.

Covid-19 and liver cirrhosis: focus on the non-classical renin-angiotensin system and implications for therapy

Sansoè G, Aragno M, Wong F.

A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease

Baker JD, Uhrich RL, Kraemer GC, Love JE, Kraemer BC.

COVID-19 risk, disparities and outcomes in patients with chronic liver disease in the United States

Wang Q, Davis PB, Xu R.

Comparison of Liver Biomarkers in 288 COVID-19 Patients: A Mono-Centric Study in the Early Phase of Pandemic

Fan H, Cai J, Tian A, Li Y, Yuan H, Jiang Z, Yu Y, Ruan L, Hu P, Yue M, Chen N, Li J, Zhu C.

Impact of liver enzymes on SARS-CoV-2 infection and the severity of clinical course of COVID-19

Higuera-de la Tijera F, Servín-Caamaño A, Reyes-Herrera D, Flores-López A, Robiou-Vivero EJA, Martínez-Rivera F, Galindo-Hernández V, Chapa-Azuela O, Chávez-Morales A, Rosales-Salyano VH.

Study on mechanism of matrine in treatment of COVID-19 combined with liver injury by network pharmacology and molecular docking technology

Liu F, Li Y, Yang Y, Li M, Du Y, Zhang Y, Wang J, Shi Y.

Hepatic vasculopathy and regenerative responses of the liver in fatal cases of COVID-19

Kaltschmidt B, Fitzek ADE, Schaedler J, Förster C, Kaltschmidt C, Hansen T, Steinfurth F, Windmöller BA, Pilger C, Kong C, Singh K, Nierhaus A, Wichmann D, Sperhake J, Püschel K, Huser T, Krüger M, Robson SC, Wilkens L, Schulte Am Esch J.

Haemophagocytic lymphohistiocytosis and liver failure-induced massive hyperferritinaemia in a male COVID-19 patient

Zellweger NM, Huber J, Tsakiris DA, Tzankov A, Gebhard CE, Siegemund M.

Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study

Weber S, Hellmuth JC, Scherer C, Muenchhoff M, Mayerle J, Gerbes AL.

Early Liver transplantation after COVID-19 infection-The first report

Kulkarni AV, Kumarswamy P, Kumar P, Sharma M, Reddy R, Chaitanya KA, Gupta R, Gupta A, Swaroop S, Premkumar GV, Senapathy G, Menon PB, Nageshwar Reddy D, Nagaraja Rao P.

SARS-CoV-2 infection in patients with autoimmune hepatitis

Marjot T, Buescher G, Sebode M, Barnes E, Barritt AS 4th, Armstrong MJ, Baldelli L, Kennedy J, Mercer C, Ozga AK, Casar C, Schramm C; Contributing Members and Collaborators of ERN RARE-LIVER / COVID-Hep / SECURE-Cirrhosis, Moon AM, Webb GJ, Lohse AW.

Chronic liver disease independently associated with COVID-19 severity: evidence based on adjusted effect estimates

Yang H, Xu J, Liang X, Shi L, Wang Y.

Racial and Socioeconomic Disparities in Utilization of Telehealth in Patients with Liver Disease During COVID-19

Wegermann K, Wilder JM, Parish A, Niedzwiecki D, Gellad ZF, Muir AJ, Patel YA.

The Covid-19 Pandemic Constraints May Lead to Disease Progression for Patients with Liver Cancer Scheduled to Receive Locoregional Therapies: Single-Centre Retrospective Analysis in an Interventional Radiology Unit

Veiga J, Amante S, Costa NV, Luz JH, Gomes FV, Coimbra É, Bilhim T.

How can we reduce the impact of COVID-19 pandemic on timely access to liver transplantation in children?

Reddy MS, Menon J, Hakeem AR, Murugesan S, Narasimhan G, Shanmugham N, Rela M.

Fusobacterium nucleatum causing a pyogenic liver abscess: a rare complication of periodontal disease that occurred during the COVID-19 pandemic

Collins L, Diamond T.

Effects of a reorganization of cirrhosis care during the lockdown for SARS-CoV-2 outbreak

Piano S, Marzioni M, Angeli P; COVID-CIRRHOSIS study group.

Mild Course of SARS-CoV-2 Infection in a Liver Transplant Recipient Undergoing Plasma Exchange and Defibrotide for Acute Graft Rejection

Merli M, Alteri C, Colagrossi L, Perricone G, Chiappetta S, Travi G, Campisi D, Pugliano MT, Vecchi M, Orcese C, Rossini S, De Carlis L, Vismara C, Belli L, Perno CF, Puoti M.

Living Donor Liver Transplantation During the COVID-19 Pandemic: A Serendipitous Silver Lining!

Menon J, Hakeem AR, Rammohan A, Sundaramoorthy S, Kanagavelu RG, Reddy MS, Rela M.

Absolute targets for HCV elimination and national health policy paradigms: Foreseeing future requirements

Kondili LA, Craxì A.

Leveraging the COVID-19 pandemic: Is it time to consider incorporating mobile applications into standard clinical management of the liver transplant patient?

Faust A, Stine JG.

Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population

Maconi G, Bosetti C, De Monti A, Boyapati RK, Shelton E, Piazza N, Carvalhas Gabrielli AM, Lenti MV, Bezzio C, Ricci C, Greco S, Romeo S, Giangregorio F, Gridavilla D, Tagliani F, Massari A, Pastorelli L, DiSabatino A, Saibeni S, Alicante S, Ferretti F, Rizzardini G, Galli M, Ardizzone S.

[Impact of COVID-19 pandemic in liver transplantation in Argentina. Other collateral damage]

Gondolesi GE, Reyes-Toso ML, Bisigniano L, de Santibañes M, Pekolj J, Maurette R, Quiñonez EG, Maraschio MA, Imventarza O, Lendoire J, Bitetti L, Ruf A, Aballay G, Gil O, Mattera FJ, Barros Schelotto P, Descalzi VI.

The transformation of cardiology training by the COVID-19 pandemic: enhancing current and future standards to deliver optimal patient care

Chong JH, Chahal A, Ricci F, Klarich K, Ferrari V, Narula J, Khanji MY.

Successful coping with SARS-CoV-2 infection of adult celiac patients assessed by telemedicine

Galli G, Esposito G, Dilaghi E, Annibale B, Lahner E, Conti L.

Characteristics of Liver transplant patients infected with COVID-19

Regmi P, Liu F, Li FY.

Successful non-directed living liver donor transplant for an infant with biliary atresia during the COVID-19 pandemic

Feldman AG, Adams MA, Wachs ME, Abzug MJ, Pratscher L, Jackson WE, Pomfret EA, Sundaram SS.

Vascular liver injury mimicking an intrahepatic cholangiocarcinoma in a COVID-19 patient

Ugolotti MC, Pedrazzini M, Silini EM, Missale G, Silva M, Franzini C, Palmieri G, Costi R, Montali F, Gnappi E, Terroni L, Colizzi E, Meschi M, Facchinetti F.

HSV1 viremia with fulminant hepatitis as opportunistic sequela in severe COVID-19

Roncati L, Manenti A, Fabbiani L, Malagoli C, Nasillo V, Lusenti B, Lupi M, Zanelli G, Salviato T, Costantini M, Trenti T, Maiorana A.

Graft Retrieval for Liver Transplant in a Donor With Giant Thoracoabdominal Aortic Aneurysm

Levi Sandri GB, Guglielmo N, Berardi G, Ettorre GM.

[The clinical application of blood routine and liver and kidney function test in COVID-19 disease prediction]

Liang YL, Ma YT, Huang KK, Luo HD, Wang AM, Xiong Z, Luo Y, Yi B.

A New Year, the top research articles, and a call to deliver a "net zero" Australian health care system by 2040

Talley NJ.

Detecting HCV infection by means of mass population SARS-CoV-2 screening: a pilot experience in Northern Italy

Giacomelli A, Pagani G, Conti F, Bassoli C, Galli M.

Response to the Letters to the Editor: COVID-19 in Patients With Pre-Existing Liver Disease

Singh S, Khan A.

COVID-19 in IBD: The experience of a single tertiary IBD center

Rizzello F, Calabrese C, Salice M, Calandrini L, Privitera H, Melotti L, Peruzzi G, Dussias N, Belluzzi A, Scaioli E, Decorato A, Siniscalchi A, Filippone E, Laureti S, Rottoli M, Poggioli G, Gionchetti P.

SARS-CoV-2 Seroprevalence and Clinical Features of COVID-19 in a German Liver Transplant Recipient Cohort: A Prospective Serosurvey Study

Rauber C, Tiwari-Heckler S, Pfeiffenberger J, Mehrabi A, Lund F, Gath P, Mieth M, Merle U, Rupp C.

Impact of Liver Injury in COVID-19 Patients: Single-center Retrospective Cohort Analysis

Desai J, Patel U, Arjun S, Farraj K, Yeroushalmi K, Paz SG, Im J, Castillo A, Rammohan R, Mustacchia P.

COVID-19 in Liver Transplant Recipients - A Series with Successful Recovery

Choudhury A, Reddy GS, Venishetty S, Pamecha V, Shasthry SM, Tomar A, Mitra LG, Prasad VST, Mathur RP, Bhattacharya D, Sarin SK.

Alcoholic Liver Disease and COVID-19 Pneumonia: A Case Series

Kapuria D, Upadhyay S, Shekhar R, Torrazza-Perez E.

What Do We Know So Far About Gastrointestinal and Liver Injuries Induced by SARS-CoV-2 Virus?

Cao W.

SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question

Marjot T, Webb GJ, Barritt AS, Ginès P, Lohse AW, Moon AM, Pose E, Trivedi P, Barnes E.

Liver injury in COVID-19: The hepatic aspect of the respiratory syndrome - what we know so far

Anirvan P, Bharali P, Gogoi M, Thuluvath PJ, Singh SP, Satapathy SK.

Liver injury after antiviral treatment of critically ill patients with COVID-19: a single-centered retrospective cohort study

Ruan X, Lu X, Wang K, Zhang B, Wang J, Li Y, Wang J, Xu Z, Yan F.

Point-of-Care Echocardiography and Hemodynamic Monitoring in Cirrhosis and Acute-on-Chronic Liver Failure in the COVID-19 Era

Premkumar M, Kajal K, Kulkarni AV, Gupta A, Divyaveer S.

Liver Injury as a Surrogate for Inflammation and Predictor of Outcomes in COVID-19

Mishra K, Naffouj S, Gorgis S, Ibrahim H, Gill S, Fadel R, Chatfield A, Tang A, Salgia R.

Liver Abnormalities after Elimination of HCV Infection: Persistent Epigenetic and Immunological Perturbations Post-Cure

Polyak SJ, Crispe IN, Baumert TF.

Correlation between liver function tests abnormalities and interleukin-6 serum levels in patients with SARS-CoV-2 infection

Romana PF, Antonio N, Fabio DZ, Francesco S, Maurizio P, Antonio G.

Tacrolimus: Unlikely harmful and perhaps helpful in liver transplant recipients with COVID-19

Pearson MM, Limaye AP, Biggins SW.

Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Tocilizumab-Containing Treatment

Kuo MH, Tseng CW, Lu MC, Tung CH, Tseng KC, Huang KY, Lee CH, Lai NS.

Mass population screening for SARS-CoV-2 and false positives-why Liverpool shows we have a problem

Cook D.

Covid-19: England tightens restrictions as NHS struggles to deliver care

Kmietowicz Z.

Molecular and cellular mechanisms of liver dysfunction in COVID-19

Huang C, Li Q, Xu W, Chen L.

COVID-19 Testing as a Contributory Cause of Delayed Treatment of a Pyogenic Liver Abscess

Ferri FA, Emberton E, Simpfendorfer CH, Roy M, Wexner SD.

Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver

Lei HY, Ding YH, Nie K, Dong YM, Xu JH, Yang ML, Liu MQ, Wei L, Nasser MI, Xu LY, Zhu P, Zhao MY.

Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis

Del Zompo F, De Siena M, Ianiro G, Gasbarrini A, Pompili M, Ponziani FR.

The liver in COVID-19: prevalence, patterns, predictors, and impact on outcomes of liver test abnormalities

Goel H, Harmouch F, Garg K, Saraiya P, Daly T, Kumar A, Hippen JT.

Low influenza vaccination coverage in subjects with liver cirrhosis. An alert waiting winter season 2020-2021 during COVID-19 pandemic

Stroffolini T, Lombardi A, Ciancio A, Niro GA, Colloredo G, Marignani M, Vinci M, Morisco F, Babudieri S, Ferrigno L, Sagnelli E.

Liver Fibrosis Index FIB-4 Is Associated With Mortality in COVID-19

Li Y, Regan J, Fajnzylber J, Coxen K, Corry H, Wong C, Rosenthal A, Atyeo C, Fischinger S, Gillespie E, Chishti R, Baden L, Yu XG, Alter G, Kim A, Li JZ.

Association of metabolic-associated fatty liver disease and risk of severe coronavirus disease 2019 illness

Sy-Janairo ML, Y Cua IH.

Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective

Hanafy AS, Abd-Elsalam S.

A computational drug repurposing approach in identifying the cephalosporin antibiotic and anti-hepatitis C drug derivatives for COVID-19 treatment

Kumar R, Kumar V, Lee KW.

Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission

Mendizabal M, Piñero F, Ridruejo E, Anders M, Silveyra MD, Torre A, Montes P, Urzúa A, Pages J, Toro LG, Díaz J, Ballerga EG, Miranda-Zazueta G, Peralta M, Gutiérrez I, Michelato D, Venturelli MG, Varón A, Pozo EV, Tagle M, García M, Tassara A, Brutti J, García SR, Bustios C, Escajadillo N, Macias Y, la Tijera FH, Gómez AJ, Dominguez A, Barradas MC, Contreras F, Scarpin A, Schinoni MI, Toledo C, Girala M, Mainardi V, Sanchez A, Bessone F, Rubinstein F, O Silva M.

Impact of the COVID 19 Pandemic on HCV Elimination in Spain

Buti M, Domínguez-Hernández R, Casado MA.

Association of ACEI/ARB, inflammatory cytokines, and antiviral drugs with liver dysfunction in patients with hypertension and COVID-19

Xiang D, Ren X, Chen Q, Yu H, Li X, Liu D.

DeepDILI: Deep Learning-Powered Drug-Induced Liver Injury Prediction Using Model-Level Representation

Li T, Tong W, Roberts R, Liu Z, Thakkar S.

Impact of COVID-19 pandemic on hepatitis C elimination from the clinical microbiologist perspective. Are we ready?

Aguilera A, Eiros JM, García F.

Clinical Characteristics of COVID-19 Patients with Hepatitis B Virus Infection - a Retrospective Study

Liu R, Zhao L, Cheng X, Huan H, Li C, Li D, Liu A, Gao G, Zhou F, Liu F, Jiang Y, Zhu C, Xia Y.

Association of liver abnormalities with in-hospital mortality in patients with COVID-19

Ding ZY, Li GX, Chen L, Shu C, Song J, Wang W, Wang YW, Chen Q, Jin GN, Liu TT, Liang JN, Zhu P, Zhu W, Li Y, Zhang BH, Feng H, Zhang WG, Yin ZY, Yu WK, Yang Y, Zhang HQ, Tang ZP, Wang H, Hu JB, Liu JH, Yin P, Chen XP, Zhang B; Tongji Multidisciplinary Team for Treating COVID-19 (TTTC).

Is positivity for hepatitis C virus antibody predictive of lower risk of death in COVID-19 patients with cirrhosis?

Mangia A, Cenderello G, Verucchi G, Ciancio A, Fontana A, Piazzolla V, Minerva N, Squillante MM, Copetti M.

Management of digestive cancers during the COVID-19 second wave: A French intergroup point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)

Tougeron D, Michel P, Lièvre A, Ducreux M, Gaujoux S, Guiu B, Huguet F, Lecomte T, Lepage C, Louvet C, Maggiori L, Mariani P, Aparicio T, Bouché O; Thésaurus National de Cancérologie Digestive (TNCD); Société Nationale Française de Gastroentérologie (SNFGE); Fédération Francophone de Cancérologie Digestive (FFCD); Groupe Coopérateur multidisciplinaire en Oncologie (GERCOR); Fédération Nationale des Centres de Lutte Contre le Cancer (UNICANCER); Société Française de Chirurgie Dig

Clinical Characteristics and Risk Factors in Coronavirus Disease 2019 Patients with Liver Injury

Zhang D, Zhu Z, Bi J, Feng D, Zhang L, Liu H, Gao Y.

Higher Mortality and Intensive Care Unit Admissions in COVID-19 Patients with Liver Enzyme Elevations

Taramasso L, Vena A, Bovis F, Portunato F, Mora S, Dentone C, Delfino E, Mikulska M, Giacobbe DR, De Maria A, Magnasco L, Giacomini M, Di Biagio A, Bassetti M.

Increased expression of key SARS-CoV-2 entry points in multiple tissues in individuals with NAFLD

Meijnikman AS, Bruin S, Groen AK, Nieuwdorp M, Herrema H.

The Covid-19 second wave risk and liver transplantation: lesson from the recent past and the unavoidable need of living donors

Di Sandro S, Magistri P, Bagnardi V, Catellani B, Guerrini GP, Di Benedetto F.

Three Consequent Pediatric Liver Transplant Deaths in the COVID-19 Era

Imam A, Karatas C, Imam R, Armutlu A, Mecit N, Karakaya A, Kalayoglu M, Kanmaz T.

Elevated liver function tests in COVID-19: Causes, clinical evidence, and potential treatments

Clark R, Waters B, Stanfill AG.

Liver disease and COVID-19: from Pathogenesis to Clinical Care

Saviano A, Wrensch F, Ghany MG, Baumert TF.

Fighting Hepatitis C in a COVID-19 ecosystem. Public health policies are needed more than ever

Lopes H, Baptista-Leite R, Franco D, Kundurzhiev T, Mateva L, Jelev D, Simonova M.

Liver injury in COVID-19 patients - a multidisciplinary experience and a call for national consensus

Roman A, Georgescu AM, Moldovan S, Stoian M, Dobru D.

Effect of Artificial Liver Blood Purification Treatment on the Survival of Critical Ill COVID-19 Patients

Xiahong D, Zhang Y, Liang Y, Ying-An J, Liang C, Ye C, Ming L, Chunming G, Jia S, Shulin X, Yongguo L, Jianzhou L, Chenliang Z, Xiaoyang Z, Nan C, Yuanchun L, Jing L, Yuanyuan Z, Xiaobei C, Danhua Z, Hainv G, Lingling T, Mengfei Z, Li L.

Covid-19: Lateral flow tests miss over half of cases, Liverpool pilot data show

Wise J.

Covid-19: Logistical problems frustrate GPs ready to deliver vaccine in England

Mahase E.

Management of gastrointestinal tuberculosis during COVID pandemic: Lessons for posterity

Shukla J, Jena A, Singh H, Mandavdhare HS, Dutta U, Sharma V.

Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction

Sikander M, Malik S, Rodriguez A, Yallapu MM, Narula AS, Satapathy SK, Dhevan V, Chauhan SC, Jaggi M.

Digestive symptoms and liver injury in patients with coronavirus disease 2019 (COVID-19): A systematic review with meta-analysis

Wan J, Wang X, Su S, Zhang Y, Jin Y, Shi Y, Wu K, Liang J.

COVID-19 in a liver transplant recipient: Could iatrogenic immunosuppression have prevented severe pneumonia? A case report

Sessa A, Mazzola A, Lim C, Atif M, Pappatella J, Pourcher V, Scatton O, Conti F.

Resuming liver transplantation amid the COVID-19 pandemic

Thorburn D, Taylor R, Whitney J, Adair A, Attia M, Gibbs P, Grammatikopoulos T, Isaac JR, Masson S, Marshall A, Mirza DF, Prachalias A, Watson S, Manas DM, Forsythe J.

Pathological findings in the postmortem liver of COVID-19 patients

Zhao CL, Rapkiewicz A, Maghsoodi-Deerwester M, Gupta M, Cao W, Palaia T, Zhou J, Ram B, Vo D, Rafiee B, Hossein-Zadeh Z, Dabiri B, Hanna I.

Protective role of tacrolimus, deleterious role of age and comorbidities in liver transplant recipients with Covid-19: results from the ELITA/ELTR multi-center European study

Belli LS, Fondevila C, Cortesi PA, Conti S, Karam V, Adam R, Coilly A, Ericzon BG, Loinaz C, Cuervas-Mons V, Zambelli M, Llado L, Diaz F, Invernizzi F, Patrono D, Faitot F, Bhooori S, Pirenne J, Perricone G, Magini G, Castells L, Detry O, Cruchaga PM, Colmenero J, Berrevoet F, Rodriguez G, Ysebaert D, Radenne S, Metselaar H, Morelli C, De Carlis L, Polak WG, Duvoux C; all the centres contributing to the ELITA-ELTR COVID-19 Registry.

Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study

Galiero R, Pafundi PC, Simeon V, Rinaldi L, Perrella A, Vetrano E, Caturano A, Alfano M, Beccia D, Nevola R, Marfella R, Sardu C, Coppola C, Scarano F, Maggi P, De Lucia Sposito P, Vocciante L, Rescigno C, Sbreglia C, Fraganza F, Parrella R, Romano A, Calabria G, Polverino B, Pagano A, Bologna C, Amitrano M, Esposito V, Coppola N, Maturo N, Adinolfi LE, Chiodini P, Sasso FC; COVOCA Study Group.

What Liver Transplant Recipients Want in a Smartphone Intervention to Enhance Recovery: Prototype for the LiveRight Transplant App

Lieber SR, Kim HP, Baldelli L, Evon DM, Teal R, Nash R, Magee G, Desai CS, Gerber D, Serrano P, Shah N, Barritt AS 4th.

The Use of Mobile-technologies to Deliver Integrative Medicine During and Beyond the COVID-19 World Pandemic

Narayanan S, Lopez G, Liu W, Cohen A, Cohen L.

ACE2: from protection of liver disease to propagation of COVID-19

Warner FJ, Rajapaksha H, Shackel N, Herath CB.

Elevated Liver Chemistries in COVID-19-Is It Not a Concern?-Authors' Reply

Hao S, Yang Y.

Elevated serum ferritin level effectively discriminates severity illness and liver injury of coronavirus disease 2019 pneumonia

Cao P, Wu Y, Wu S, Wu T, Zhang Q, Zhang R, Wang Z, Zhang Y.

Pre-existing Liver Diseases and On-Admission Liver-Related Laboratory Tests in COVID-19: A Prognostic Accuracy Meta-Analysis With Systematic Review

Váncsa S, Hegyi PJ, Zádori N, Szakó L, Vörhendi N, Ocskay K, Földi M, Dembrovszky F, Dömötör ZR, Jánosi K, Rakonczay Z Jr, Hartmann P, Horváth T, Erőss B, Kiss S, Szakács Z, Németh D, Hegyi P, Pár G.

The Heightened Risk of Fatty Liver Disorders in the Time of COVID-19

Stanfield D, Lucey MR.

Effect of SARS-CoV-2 coinfection was not apparent on the dynamics of chronic hepatitis B infection

Yu R, Tan S, Dan Y, Lu Y, Zhang J, Tan Z, He X, Xiang X, Zhou Y, Guo Y, Deng G, Chen Y, Tan W.

COVID-19 and Liver Transplantation: Early Reports and Recommendations

Giannis D, Moris D.

Covid-19: Concerns persist about purpose, ethics, and effect of rapid testing in Liverpool

Wise J.

How an endoscopy unit changed and was partially converted into an ICU during COVID-19 emergency in a tertiary referral hospital of Northern Italy

Mirante VG, Mazzi G, Bevivino G, Parmeggiani F, Iori G, Sassatelli R.

Impact of liver injury on the severity of COVID-19: Systematic Review with Meta-analysis

Ampuero J, Sánchez-Torrijos Y, García Lozano MDR, Maya D, Romero-Gómez M.

Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines

Pleyer C, Ali MA, Cohen JI, Tian X, Soto SJ, Ahn IE, Gaglione EM, Nierman PK, Marti GE, Hesdorffer C, Lotter J, Superata J, Wiestner A, Sun C.

Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)

Li X.

A Multicentric Experience on Living Donor Liver Transplantation in COVID-19 Hotspots in India

Varghese J, Malleeswaran S, Patcha RV, Appusamy E, Karnan P, Kapoor D, Kota V, Kedarisetty CK, Singh B, Rao PS, Yalakanti RB, Mohanka R, Shrimal A, Nikam V, Kumar K, Shenvi SD, Pillai VB, Heaton ND.

Successful liver transplantation immediately after recovery from COVID-19 in a highly endemic area

Raut V, Sonavane A, Shah K, Amruthraj C, Thorat A, Sawant A, Chaksota H, Mandot A, Vasanth S, Nagral A, Mirza D.

Lethal outcome of Covid-19 pneumonia in a new liver recipient with neurological manifestation

Eslami P, Moradi M, Dooghaie Moghadam A, Pirsalehi A, Abdul Lateef S, Hadaegh A, Rezai B, Sadeghi A, Asadzadeh Aghdaei H, Zali MR.

Presentation of COVID-19 in a liver transplant recipient

Hatami B, Ketabi Moghadam P, Zali M.

COVID-19 prognosis: what we know of the significance and prognostic value of liver-related laboratory parameters in SARS-CoV-2 infection

Bashash D, Olfatifar M, Hadaegh F, Asadzadeh Aghdaei H, Zali MR.

Positive association between severity of COVID-19 infection and liver damage: a systematic review and meta-analysis

Shokri Afra H, Amiri-Dashatan N, Ghorbani F, Maleki I, Rezaei-Tavirani M.

Increased inflammatory markers correlate with liver damage and predict severe COVID-19: a systematic review and meta-analysis

Amiri-Dashatan N, Koushki M, Ghorbani F, Naderi N.

Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020

Simões D, Stengaard AR, Combs L, Raben D; EuroTEST COVID-19 impact assessment consortium of partners.

Convalescent plasma therapy and remdesivir duo successfully salvaged an early liver transplant recipient with severe COVID-19 pneumonia

Jamir I, Lohia P, Pande RK, Setia R, Singhal AK, Chaudhary A.

Liver Injury in Hospitalized Patients with COVID-19 Correlates with Hyper Inflammatory Response and Elevated IL-6

Da BL, Kushner T, El Halabi M, Paka P, Khalid M, Uberoi A, Lee BT, Perumalswami PV, Rutledge SM, Schiano TD, Friedman S, Saberi B.

WGO Guidance for the Care of Patients With COVID-19 and Liver Disease

Hamid S, Alvares da Silva MR, Burak KW, Chen T, Drenth JPH, Esmat G, Gaspar R, LaBrecque D, Lee A, Macedo G, McMahon B, Ning Q, Reau N, Sonderup M, van Leeuwen DJ, Armstrong D, Yurdaydin C.

Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Minorities with Chronic Liver Diseases (CLD)

Adeniji N, Carr RM, Aby ES, Catana AM, Wegermann K, Dhanasekaran R.

Ketamine-Induced Sclerosing Cholangitis (KISC) in a Critically Ill Patient with COVID-19

Knooihuizen SAI, Aday A, Lee WM.

Impact of the 2020 COVID-19 Pandemic on Ambulatory Hepatitis C Testing

Sperring H, Ruiz-Mercado G, Schechter-Perkins EM.

Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury

Lin Y, Yuan J, Long Q, Hu J, Deng H, Zhao Z, Chen J, Lu M, Huang A.

NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues

Mushtaq K, Khan MU, Iqbal F, Alsoub DH, Chaudhry HS, Ata F, Iqbal P, Elfert K, Balaraju G, Almaslamani M, Al-Ejji K, AlKaabi S, Kamel YM.

Obesity, Diabetes, Non-alcoholic Fatty Liver Disease and Metabolic Dysfunction Associated Fatty Liver Disease are Proinflammatory Hypercoagulable States associated with Severe Disease and Thrombosis in Covid-19

Ji D, Zhang M, Qin E, Zhang L, Xu J, Wang Y, Cheng G, Wang F, Lau G.

Does MAFLD really increase the severity of COVID-19?

Fajar JK, Wibowo BP, Dewi GC, Rahmadi AP, Kusuma MT.

Liver transplantation in a patient with human immunodeficiency virus and COVID-19

Tabrizian P, Pourmand K, Florman S.

Enabling liver transplantation during the COVID-19 era: More than screening donors and recipients for SARS-CoV-2

Abdala E, Waisberg DR, Haddad LB, Ducatti L, Rocha-Santos V, de Martino RB, Andraus W, Carneiro-D'Albuquerque LA.

COVID-19 and Liver Damage: Narrative Review and Proposed Clinical Protocol for Critically ill Pediatric Patients

Luglio M, Tannuri U, de Carvalho WB, Bastos KLM, Rodriguez IS, Johnston C, Delgado AF.

Giant Cavernous Hemangioma of the Liver in a Patient with Autosomal Dominant Polycystic Kidney Disease

Ghenu IM, Constantin R, Ionescu D, Dragos D.

Genetic insight into COVID-19 related liver injury: a note on MBOAT7

Machill A, Bals R, Lammert F, Krawczyk M.

Severe COVID-19 after liver transplantation, surviving the pitfalls of learning on-the-go: Three case reports

Alconchel F, Cascales-Campos PA, Pons JA, Martínez M, Valiente-Campos J, Gajownik U, Ortiz ML, Martínez-Alarcón L, Parrilla P, Robles R, Sánchez-Bueno F, Moreno S, Ramírez P.

COVID-19 infection in first trimester of pregnancy marked by a liver cytolysis in a woman previously treated by hydroxychloroquine for repeated implantation failure: a case report

Lamazou F, Oger P, Dieli-Crimi R, Guerin A, Letouzey V, Octernaud S, Place V, Calès P, Descamps P, Delaroche L.

Multicenter Analysis of Liver Injury Patterns and Mortality in COVID-19

Chu H, Bai T, Chen L, Hu L, Xiao L, Yao L, Zhu R, Niu X, Li Z, Zhang L, Han C, Song S, He Q, Zhao Y, Zhu Q, Chen H, Schnabl B, Yang L, Hou X.

Business-as-Usual will not Deliver the COVID-19 Vaccines We Need

Torreele E.

Pathophysiological mechanisms of liver injury in COVID-19

Nardo AD, Schneeweiss-Gleixner M, Bakail M, Dixon ED, Lax SF, Trauner M.

SARS-CoV-2 infection in patients with a normal or abnormal liver

Cabibbo G, Rizzo GEM, Stornello C, Craxì A.

Letter to the Editors: More Efforts for Detecting the Elevated Liver Biochemistries in Patients with Severe COVID-19

Lin YM, Cui AY, Wang DW, Lu HD.

Severe liver injury of Coronavirus Disease 2019 (COVID-19) in recovery

Zhou WQ, Chen Y, Liu D, Yang DL, Zheng X.

Reply to "Does MAFLD really increase the severity of COVID-19?"

Pan L, Huang P, Xie X, Xu J, Guo D, Jiang Y.

COVID-19 and pneumatosis intestinalis: An early sign of intestinal ischemia

Hassan W, Ramadan HK.

Trust in telemedicine from IBD outpatients during the COVID-19 pandemic

Costantino A, Noviello D, Mazza S, Berté R, Caprioli F, Vecchi M.

COVID 19 and the Liver

Shukla A, Mohanka R.

COVID-19 associated variations in liver function parameters: a retrospective study

Saini RK, Saini N, Ram S, Soni SL, Suri V, Malhotra P, Kaur J, Verma I, Sharma S, Zohmangaihi D.

Prolonged shedding of SARS-CoV-2 in an elderly liver transplant patient infected by COVID-19: a case report

Wei L, Liu B, Zhao Y, Chen Z.

Impact of the first Covid-19 outbreak on liver transplantation activity in France: A snapshot

Turco C, Lim C, Soubrane O, Malaquin G, Kerbaul F, Bastien O, Conti F, Scatton O.

Risk factors of liver injury in patients with coronavirus disease 2019 in Jiangsu, China: a retrospective, multi-center study

Wang J, Zhu L, Xue L, Liu L, Yan X, Yan X, Huang S, Zhang B, Xu T, Li C, Ji F, Ming F, Zhao Y, Cheng J, Shao H, Chen K, Zhao XA, Sang D, Zhao H, Guan X, Chen X, Chen Y, Liu J, Huang R, Zhu C, Wu C.

APASL practical recommendations for the management of hepatocellular carcinoma in the era of COVID-19

Shiina S, Gani RA, Yokosuka O, Maruyama H, Nagamatsu H, Payawal DA, Dokmeci AK, Lesmana LA, Tanwandee T, Lau G, Sarin SK, Omata M.

Covid-19: GPs to get £12.58 per dose to deliver vaccine from December

Iacobucci G.

COVID-19 in the Early Postoperative Period of Liver Transplantation: Is the Outcome Really So Positive?

Waisberg DR, Abdala E, Nacif LS, Ducatti L, Haddad LB, Martino RB, Pinheiro RS, Arantes RM, Galvao FH, Gouveia LN, Terrabuio DR, Darce GF, Rocha-Santos V, Andraus W, Carneiro-D'Albuquerque LA.

Incidence and Outcomes of COVID-19 in Kidney and Liver Transplant Recipients With HIV: Report From the National HOPE in Action Consortium

Mehta SA, Rana MM, Motter JD, Small CB, Pereira MR, Stosor V, Elias N, Haydel B, Florman S, Odim J, Morsheimer M, Robien M, Massie AB, Brown D, Boyarsky B, Garonzik Wang J, Tobian AAR, Werbel WA, Segev DL, Durand CM; HOPE in Action Investigators..

Application value of artificial liver support system in the treatment of cytokine storm in patients with COVID-19

Xia Q, Xu K, Yu L, Zhang H, Li L.

COVID-19 and liver disease: not all evil comes to harm

Marabotto E, Ziola S, Djahandideh Sheijani A, Giannini EG.

Post liver transplant recurrent and de novo viral infections

Jothimani D, Venugopal R, Vij M, Rela M.

Prognostic value of liver biochemical parameters for COVID-19 mortality

Ye L, Chen B, Wang Y, Yang Y, Zeng J, Deng G, Deng Y, Zeng F.

Addressing Social Determinants of Liver Disease during the COVID-19 Pandemic and Beyond: A Call to Action

Kardashian A, Wilder J, Terrault NA, Price JC.

Covid-19: GPs are told to be ready to deliver vaccine from next month

Iacobucci G.

A meta-analysis of the impact of COVID-19 on liver dysfunction

Wu ZH, Yang DL.

Liver injury with COVID-19 based on gastrointestinal symptoms and pneumonia severity

Kaneko S, Kurosaki M, Nagata K, Taki R, Ueda K, Hanada S, Takayama K, Suzaki S, Harada N, Sugiyama T, Nagasawa M, Izumi N.

Management of Hepatocellular Carcinoma during the COVID-19 Pandemic - São Paulo Clínicas Liver Cancer Group Multidisciplinary Consensus Statement

Chagas AL, Fonseca LGD, Coelho FF, Saud LRDC, Abadala E, Andraus W, Fiore L, Moreira AM, Menezes MR, Carnevale FC, Tani CM, Alencar RSSM, D'Albuquerque LAC, Herman P, Carrilho FJ.

Covid-19: Mass population testing is rolled out in Liverpool

Iacobucci G.

Liver Biopsy Shines a Light on COVID-19-Related Liver Injury

Kleiner DE.

Liver and Kidney Transplant During a 6-Month Period in the COVID-19 Pandemic: A Single-Center Experience

Akdur A, Karakaya E, Ayvazoglu Soy EH, Yarbug Karakayali F, Yildirim S, Torgay A, Sayin CB, Coskun M, Moray G, Haberal M.

COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms

Zhong P, Xu J, Yang D, Shen Y, Wang L, Feng Y, Du C, Song Y, Wu C, Hu X, Sun Y.

Liver function test abnormalities are associated with a poorer prognosis in Covid-19 patients: Results of a French cohort

Chaibi S, Boussier J, Hajj WE, Abitbol Y, Taieb S, Horaist C, Jouannaud V, Wang P, Piquet J, Maurer C, Lahmek P, Nahon S.

COVID-19 and liver transplantation: the jury is still out

Tavabie OD, Abeysekera KWM, Tranah TH, Nayagam JS, Aluvihare VR.

COVID-19 and liver transplantation: the jury is still out - Authors' reply

Webb GJ, Marjot T, Barnes E, Barritt AS 4th, Moon AM.

The indicative role of markers for liver injury on the severity and prognosis of coronavirus disease 2019 patients

Yang R, Gui X, Ke H, Gao S, Luo M, Xiong Y.

Lopinavir-Ritonavir and Liver Involvement in Patients With COVID-19

Lv XH, Yang JL, Deng K.

Liver Transplantation Activity in the Eurotransplant Area Is Recovering Slowly During the COVID-19 Crisis

Putzer G, Martini J, Gasteiger L, Mathis S, Breitkopf R, Hell T, van Enckevort A, Oberhuber R, Öfner D, Schneeberger S.

Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group

Arrigo S, Alvisi P, Banzato C, Bramuzzo M, Civitelli F, Corsello A, D'Arcangelo G, Lillo AD, Dipasquale V, Felici E, Fuoti M, Gatti S, Giusti Z, Knafelz D, Lionetti P, Mario F, Marseglia A, Martelossi S, Moretti C, Norsa L, Nuti F, Panceri R, Rampado S, Renzo S, Romano C, Romeo E, Strisciuglio C, Martinelli M.

Fecal calprotectin levels in COVID-19: Lessons from a systematic review on its use in inflammatory bowel disease during the pandemic

Jena A, Kumar-M P, Singh AK, Sharma V.

Liver transplantation in COVID-19 positive patients

Raveh Y, Simkins J, Nicolau-Raducu R.

Inflammatory cytokines, T lymphocyte subsets, and ritonavir involved in liver injury of COVID-19 patients

Liao S, Zhan K, Gan L, Bai Y, Li J, Yuan G, Cai Y, Zhang A, He S, Mei Z.

Reply to: 'NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression-The debate continues'

Ji D, Cheng G, Lau G.

Incidence, patterns, risk factors, and histopathological findings of liver injury in coronavirus disease 2019 (COVID-19): a scoping review

Bin Arif T, Khalid S, Siddiqui MS, Hussain H, Sohail H.

No association between COVID-19 related liver injury and the course of disease: a retrospective study

Sikkema BJB, Sint Nicolaas JJ, van Wijngaarden PP.

The Prevalence of Gastrointestinal Symptoms, Abnormal Liver Function, Digestive System Disease and Liver Disease in COVID-19 Infection: A Systematic Review and Meta-Analysis

Dong ZY, Xiang BJ, Jiang M, Sun MJ, Dai C.

In-hospital Mortality after Liver Transplantation due to COVID-19

Bhatti ABH, Riyaz S, Akhtar A.

How do we respond to COVID-19 pandemic with rapid rescue plan for ALF/ACLF patients by living-donor liver transplantation?

He K, Qian Y, Xi Z, Zhao J, Chen X, Xia Q.

Healthcare for non-Covid-19 liver disease patients during the Covid-19 pandemic in Bangladesh: Current trend and future implications

Faizul Huq AKM, Al Mahtab M, Choudhury N, Alia RA, Uddin MH, Mahtab M, Khan MSI, Rahman Z, Akbar SMF.

Online Liver Imaging Course; Pivoting to Transform Radiology Education During the SARS-CoV-2 Pandemic

Elsayes KM, Marks RM, Kamel S, Towbin AJ, Kielar AZ, Patel P, Chernyak V, Fowler KJ, Nassar S, Soliman MA, Kamaya A, Mendiratta-Lala M, Borhani AA, Fetzer DT, Fung AW, Do RKG, Bashir MR, Lee J, Consul N, Olmsted R, Kambadone A, Taouli B, Furlan A, Sirlin CB, Hsieh P.

The Liver in COVID-19-Related Death: Protagonist or Innocent Bystander?

Schmit G, Lelotte J, Vanhaebost J, Horsmans Y, Van Bockstal M, Baldin P.

Management of Patients with Liver Transplant and Chronic Liver Diseases During COVID-19 Pandemic: A Brief Review

Taher M, Miroliaee A, Ebrahimi Daryani N, Alborzi Avanaki F, Aletaha N, Nasiri-Toosi M, Dashti H, Basirat V, Jafarian A.

Liver transplantation in the United States during the COVID-19 pandemic: national and center-level responses

Strauss AT, Boyarsky BJ, Garonzik Wang JM, Werbel W, Durand CM, Avery RK, Jackson KR, Kernodle AB, Baker T, Snyder J, Segev DL, Massie AB.

Prognosis and Treatment of Liver Transplant Recipients in the COVID-19 Era: A Literature Review

Imam A, Abukhalaf SA, Merhav H, Abu-Gazala S, Cohen-Arazi O, Pikarsky AJ, Safadi R, Khalaileh A.

[Elimination of hepatitis C, our progress, challenges and hopes]

Rao HY, Li MY, Wei L.

COVID-19 Patients With Hepatitis B Virus Infection

Lv XH, Yang JL, Deng K.

Update on Hepatitis C Epidemiology: Unaware and Untreated Infected Population Could Be the Key to Elimination

Stasi C, Silvestri C, Voller F.

Tocilizumab and liver injury in patients with COVID-19

Serviddio G, Villani R, Stallone G, Scioscia G, Foschino-Barbaro MP, Lacedonia D.

SARS-CoV-2 infection and the gut-liver axis

Mohandas S, Vairappan B.

Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)

Lopez-Mendez I, Aquino-Matus J, Gall SM, Prieto-Nava JD, Juarez-Hernandez E, Uribe M, Castro-Narro G.

Genetic insight into Covid-19 related liver injury

Bianco C, Baselli G, Malvestiti F, Santoro L, Pelusi S, Manunta M, Grasselli G, Bandera A, Scudeller L, Prati D, Valenti L.

Prevalence of liver injury in patients with coronavirus disease 2019 (COVID-19) : a systematic review and meta-analysis

Merola E, Pravadelli C, de Pretis G.

Keep calm and carry on learning: using Microsoft Teams to deliver a medical education programme during the COVID-19 pandemic

Henderson D, Woodcock H, Mehta J, Khan N, Shivji V, Richardson C, Aya H, Ziser S, Pollara G, Burns A.

Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection

Hariyanto TI, Prasetya IB, Kurniawan A.

Liver injury in COVID-19: A minireview

Zhao JN, Fan Y, Wu SD.

Liver Injury in COVID-19: Caution and Management

Cao J, Cai X, Chen M.

Liver Dysfunction and Its Association with the Risk of Death in COVID-19 Patients: A Prospective Cohort Study

Fu L, Fei J, Xu S, Xiang HX, Xiang Y, Hu B, Li MD, Liu FF, Li Y, Li XY, Zhao H, Xu DX.

Impacts of COVID-19 on Liver Cancers: During and after the Pandemic

Chan SL, Kudo M.

Liver disease and outcomes among COVID-19 hospitalized patients- a systematic review and meta-analysis

Sharma A, Jaiswal P, Kerakhan Y, Saravanan L, Murtaza Z, Zergham A, Honganur NS, Akbar A, Deol A, Francis B, Patel S, Mehta D, Jaiswal R, Singh J, Patel U, Malik P.

Spontaneous Intraparenchymal Hepatic Hemorrhage as a Sequela of COVID-19

Daid SS, Toribio AD, Lakshmanan S, Sadda A, Epstein A.

Repurposing Hepatitis C Direct -acting antivirals against COVID-19

Kumar P, Kulkarni A, Sharma M, Nagaraja Rao P.

Fulminant hepatic failure: A rare and devastating manifestation of Coronavirus disease 2019 in an 11-year-old boy

Haji Esmaeil Memar E, Mamishi S, Sharifzadeh Ekbatani M, Alimadadi H, Yaghmaei B, Chegini V, Janani S, Mahmoudi S.

Midwives and paramedics can deliver flu and covid vaccines after new laws come into force

Mahase E.

Splanchnic vein thrombosis in COVID-19: A review of literature

Singh B, Kaur P, Maroules M.

COVID-19 and intestinal inflammation: Role of fecal calprotectin

Ojetti V, Saviano A, Covino M, Acampora N, Troiani E, Franceschi F; GEMELLI AGAINST COVID‐19 group.

Covid-19: Liverpool's intensive care and critical care beds are "filling up fast," health leader warns

Limb M.

Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea

Lee YR, Kang MK, Song JE, Kim HJ, Kweon YO, Tak WY, Jang SY, Park JG, Lee C, Hwang JS, Jang BK, Suh JI, Chung WJ, Kim BS, Park SY.

Clinical features and risk factors of COVID-19-associated liver injury and function: A retrospective analysis of 830 cases

Chen F, Chen W, Chen J, Xu D, Xie W, Wang X, Xie Y.

Restructuring Living Donor Liver Transplantation at a High Volume Center During the COVID-19 Pandemic

Soin AS, Choudhary NS, Yadav SK, Saigal S, Saraf N, Rastogi A, Bhangui P, Srinivasan T, Mohan N, Saha SK, Gupta A, Chaudhary RJ, Yadav K, Dhampalwar S, Govil D, Gupta N, Vohra V.

Correlation of liver-to-spleen ratio, lung CT scores, clinical, and laboratory findings of COVID-19 patients with two consecutive CT scans

Guler E, Unal NG, Cinkooglu A, Savas R, Kose T, Pullukcu H, Harman M, Elmas NZ, Ramaiya NH, Ozutemiz AO.

Statins in liver cirrhosis in a developing country: benefits overweigh the risk?

Gonzáles Yovera JG, Concepción-Zavaleta MJ, Moreno Marreros DM, Armas Flóres CD.

Liver Transplantation in a Patient after COVID-19 - rapid loss of antibodies and prolonged Viral RNA Shedding

Niess H, Börner N, Muenchhoff M, Khatamzas E, Stangl M, Graf A, Girl P, Georgi E, Koliogiannis D, Denk G, Irlbeck M, Werner J, Guba M.

The association of coagulopathy with liver dysfunction in patients with COVID-19

Tsutsumi T, Saito M, Nagai H, Yamamoto S, Ikeuchi K, Lim LA, Adachi E, Koga M, Okushin K, Akai H, Kunimatsu A, Yotsuyanagi H.

Metabolic associated fatty liver disease and COVID-19: a double whammy?

Lin HXJ, Aravamudan VM.

Detected SARS-CoV-2 in Ascitic Fluid Followed by Cryptococcemia: a Case Report

Passarelli VC, Perosa AH, de Souza Luna LK, Conte DD, Nascimento OA, Ota-Arakaki J, Bellei N.

A Case of Fulminant Liver Failure in a 24-Year-Old Man with Coinfection with Hepatitis B Virus and SARS-CoV-2

Ali E, Ziglam H, Kohla S, Ahmed M, Yassin M.

The Impact of COVID-19 on Organ Donation, Procurement and Liver Transplantation in the United States

Merola J, Schilsky ML, Mulligan DC.

Successful Liver Transplantation in a Patient Recovered from COVID-19

Dhand A, Bodin R, Wolf DC, Schluger A, Nabors C, Nog R, Diflo T, Nishida S.

Pattern of liver function and clinical profile in COVID-19: A cross-sectional study of 91 patients

Kumar A, Kumar P, Dungdung A, Kumar Gupta A, Anurag A, Kumar A.

SARS-CoV-2 massive testing: a window of opportunity to catch up with HCV elimination

Crespo J, Díaz-González Á, Iruzubieta P, Llerena S, Cabezas J.

Endoscopic ultrasound-guided gastro-enteric anastomosis in the COVID era: May the pandemic emphasize the benefit?

Fugazza A, Spadaccini M, Bramanti S, Castoro C, Repici A, Anderloni A.

Recovery of Moderate Coronavirus Disease 2019 in a Liver Transplant Recipient on Continued Immunosuppression: A Case Report

Mathiasen VD, Oversoe SK, Ott P, Jensen-Fangel S, Leth S.

COVID-19: discovery, diagnostics and drug development

Asselah T, Durantel D, Pasmant E, Lau G, Schinazi RF.

Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study

Marjot T, Moon AM, Cook JA, Abd-Elsalam S, Aloman C, Armstrong MJ, Pose E, Brenner EJ, Cargill T, Catana MA, Dhanasekaran R, Eshraghian A, García-Juárez I, Gill US, Jones PD, Kennedy J, Marshall A, Matthews C, Mells G, Mercer C, Perumalswami PV, Avitabile E, Qi X, Su F, Ufere NN, Wong YJ, Zheng MH, Barnes E, Barritt AS 4th, Webb GJ.

Light at the end of the tunnel: COVID-19 lockdown has not halted liver transplantation at a high volume center in Italy

Melandro F, Ghinolfi D, Balzano E, Tincani G, Catalano G, Biancofiore G, Peris A, De Simone P.

Unexpected better outcome in a liver transplant recipient with COVID-19: a beneficial effect of tacrolimus?

García-Juárez I, Campos-Murguía A, Tovar-Méndez VH, Gabutti A, Ruiz I.

Liver injury could be associated with severe disease in COVID-19 patients: a meta-analysis

Liu C, Yang J, Wang W, Zheng P, Tang Y.

Combination of CLIF-OF and CCI predicts survival in patients with cirrhosis and COVID-19

Iavarone M, D'Ambrosio R, Lampertico P.

Unsafe Supply: Why Making Controlled Prescription Drugs Available for Unsupervised Use Will Not Target the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19-- A Commentary on Bonn et al. (2020)

Lembke A.

Addressing the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19 Among People Who Use Drugs: The Potential Roles for Decriminalization and Safe Supply

Bonn M, Palayew A, Bartlett S, Brothers TD, Touesnard N, Tyndall M.

Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China

Wang M, Yan W, Qi W, Wu D, Zhu L, Li W, Wang X, Ma K, Ni M, Xu D, Wang H, Chen G, Yu H, Ding H, Xing M, Han M, Luo X, Chen T, Guo W, Xi D, Ning Q.

Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis

Cardinale V, Capurso G, Ianiro G, Gasbarrini A, Arcidiacono PG, Alvaro D.

Pediatric liver transplantation and COVID-19: a case report

Nikoupour H, Kazemi K, Arasteh P, Ghazimoghadam S, Eghlimi H, Dara N, Gholami S, Nikeghbalian S.

Heavy charged particle beam therapy and related new radiotherapy technologies: The clinical potential, physics and technical developments required to deliver benefit for patients with cancer

Kirkby KJ, Kirkby NF, Burnet NG, Owen H, Mackay RI, Crellin A, Green S.

Outcomes of COVID-19 in living donor liver transplant (LDLT) recipients

Dhampalwar S, Saigal S, Choudhary N, Saraf N, Bhangui P, Rastogi A, Thiagrajan S, Soin AS.

Successful Orthotopic Liver Transplantation in a Patient with a Positive SARS-CoV2 Test and Acute Liver Failure Secondary to Acetaminophen Overdose

Rouphael C, D'Amico G, Ricci K, Cywinski J, Miranda C, Koval C, Duggal A, Quintini C, Menon KN, Miller C, Modaresi Esfeh J.

Editorial: intended victim or innocent bystander? The liver in COVID-19

Packer G, Bangash MN.

Letter: elevated liver enzymes and outcome in COVID-19

Elhence A, Kumar R, Shalimar.

Letter: liver involvement and mortality in COVID-19 patients - authors' reply

Ponziani FR, Del Zompo F, Nesci A, Santopaolo F, Ianiro G, Gasbarrini A, Pompili M; “Gemelli against COVID‐19” group.

Letter: elevated liver enzymes and outcomes in COVID Authors' reply

Kulkarni AV, Kumar P, Tevethia HV, Arab JP, Candia R, Premkumar M, Sharma M, Rao PN, Reddy DN.

Editorial: intended victim or innocent bystander? The liver in COVID-19-Authors' reply

Huang H, Chen S, Li H, Zhou XL, Dai Y, Wu J, Zhang J, Shao L, Yan R, Wang M, Wang J, Tu Y, Ge M.

Letter: liver involvement and mortality in COVID-19 patients

Lv XH, Yang JL, Deng K.

The Model for End-Stage Liver Disease-Sodium Score at Admission Is Prognostic of Covid-19 Disease Severity

Wagner J, Garcia-Rodriguez V, Yu A, Dutra B, Bhatt A, Larson S, Farooq A.

A Case Report of Progressive Liver Failure Inappropriate to Decompensated Heart Failure Following Infection With COVID-19

Makarem J, Naghibi N, Beigmohammadi MT, Foroumandi M, Mehrpooya M.

Systematic review on failure to adhere to IBD therapies during the COVID-19 pandemic: Correct information is crucial

Jena A, Singh AK, Kumar-M P, Sharma V, Sebastian S.

Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis

Pan L, Huang P, Xie X, Xu J, Guo D, Jiang Y.

Jaundice in a patient treated with Anakinra in a context of Covid-19

Tarhini H, Husain M, Poey N, Lariven S, Lescure FX, Yazdanpanah Y, Gervais A.

Clinical Characteristics, Hospitalization and Mortality Rates of COVID-19 Among Liver Transplant Patients in the United States: A Multi-Center Research Network Study

Mansoor E, Perez A, Abou-Saleh M, Sclair SN, Cohen S, Cooper GS, Mills A, Schlick K, Khan A.

Acetylcysteine for the Treatment of Suspected Remdesivir-Associated Acute Liver Failure in COVID-19: A Case Series

Carothers C, Birrer K, Vo M.

Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study

Ianiro G, Bibbò S, Masucci L, Quaranta G, Porcari S, Settanni CR, Lopetuso LR, Fantoni M, Sanguinetti M, Gasbarrini A, Cammarota G.

Impact of COVID-19 pandemic on chronic pain management: Looking for the best way to deliver care

Puntillo F, Giglio M, Brienza N, Viswanath O, Urits I, Kaye AD, Pergolizzi J, Paladini A, Varrassi G.

Analysis of liver injury factors in 332 patients with COVID-19 in Shanghai, China

Guo H, Zhang Z, Zhang Y, Liu Y, Wang J, Qian Z, Zou Y, Lu H.

Clinical Features and Liver Injury in Patients with COVID-19 in the Japanese Population

Abe K, Yamamoto T, Matsumoto K, Kikuchi K, Miura R, Tachizawa N, Asaoka Y, Takezawa T, Matsunaga N, Obi S, Tanaka A.

Covid-19: Politicians must be honest about what NHS can deliver during pandemic, say leaders

Iacobucci G.

A prospective, multi-centre external validation study of the Liverpool Peritonsillar abscess Score (LPS) with a no-examination Covid-19 modification

Selwyn D, Yang D, Heward E, Kerai A, Thompson E, Shommakhi A, Faulkner S, Siau R, Walijee H, Hampton T, Chudek D, Singhera S, Din W, Lau AS.

Findings of Severe Hepatic SARS-CoV-2 Infection

Fiel MI, El Jamal SM, Paniz-Mondolfi A, Gordon RE, Reidy J, Bandovic J, Advani R, Kilaru S, Pourmand K, Ward S, Thung SN, Schiano T.

COVID-19 in decompensated cirrhosis

Rela M, Patil V, Narasimhan G, Jothimani D.

Correlation analysis of coagulation dysfunction and liver damage in patients with novel coronavirus pneumonia: a single-center, retrospective, observational study

Chen S, Liu H, Li T, Huang R, Gui R, Zhang J.

COVID 19 and liver: An A-Z literature review

Metawea MI, Yousif WI, Moheb I.

Acute Liver Failure in a COVID-19 Patient Without any Preexisting Liver Disease

Gurala D, Al Moussawi H, Philipose J, Abergel JR.

Gastrointestinal Symptoms and Elevation in Liver Enzymes in COVID-19 Infection: A Systematic Review and Meta-Analysis

Puli S, Baig M, Walayat S.

Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in Coronavirus Disease-19

Chen VL, Hawa F, Berinstein JA, Reddy CA, Kassab I, Platt KD, Hsu CY, Steiner CA, Louissaint J, Gunaratnam NT, Sharma P.

Liver transplantation in Italy in the era of COVID 19: reorganizing critical care of recipients

Siniscalchi A, Vitale G, Morelli MC, Ravaioli M, Laici C, Bianchini A, Del Gaudio M, Conti F, Vizioli L, Cescon M.

Liver Transplant in a Recently COVID-19 Positive Child with Hepatoblastoma

Goss MB, Munoz FM, Ruan W, Galván NTN, O'Mahony CA, Rana A, Cotton RT, Moreno NF, Heczey AA, Leung DH, Goss JA.

Hepatic Injury in Patients With COVID-19

Kullar R, Patel AP, Saab S.

Nosocomial COVID-19 Infection and Severe COVID-19 Pneumonia in Patients Hospitalized for Alcoholic Liver Disease: A Case Report

Wiśniewska H, Skowron M, Bander D, Hornung M, Jurczyk K, Karpińska E, Laurans Ł, Socha Ł, Czajkowski Z, Wawrzynowicz-Syczewska M.

Low risk of hepatitis b reactivation in patients with severe COVID-19 who receive immunosuppressive therapy

Rodríguez-Tajes S, Miralpeix A, Costa J, López-Suñé E, Laguno M, Pocurull A, Lens S, Mariño Z, Forns X.

Liver Injury in Liver Transplant Recipients with Coronavirus Disease 2019 (COVID-19): US Multicenter Experience

Rabiee A, Sadowski B, Adeniji N, Perumalswami P, Nguyen V, Moghe A, Latt N, Kumar S, Aloman C, Catana AM, Bloom PP, Chavin K, Carr RM, Dunn W, Chen V, Aby ES, Debes J, Dhanasekaran R; COLD Consortium.

Anakinra for COVID-19: how to interpret elevations in serum liver enzymes

Cavalli G, Dagna L.

COVID-19 and the liver: What do we know after six months of the pandemic?

Fierro NA.

SARS-CoV-2 infection in liver transplant recipients: collaboration in the time of COVID-19

Heimbach JK, Taner T.

Management of hepatitis C in children and adolescents during COVID-19 pandemic

Pokorska-Åšpiewak M, Åšpiewak M.

Mechanisms and consequences of COVID-19 associated liver injury: What can we affirm?

Brito CA, Barros FM, Lopes EP.

Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?

Ferron PJ, Gicquel T, Mégarbane B, Clément B, Fromenty B.

Hepatology and the "new reality" ushered in by the COVID-19 pandemic

Uribe M, Aquino-Matus J.

Covid-19 can mimic acute cholecystitis and is associated with the presence of viral RNA in the gallbladder wall

Balaphas A, Gkoufa K, Meyer J, Peloso A, Bornand A, McKee TA, Toso C, Popeskou SG.

Complicated COVID-19 in pregnancy: a case report with severe liver and coagulation dysfunction promptly improved by delivery

Ronnje L, Länsberg JK, Vikhareva O, Hansson SR, Herbst A, Zaigham M.

Liver injury in patients with COVID-19: clinical profiles, CT findings, the correlation of the severity with liver injury

Lei P, Zhang L, Han P, Zheng C, Tong Q, Shang H, Yang F, Hu Y, Li X, Song Y.

Clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan

Zhang H, Liao YS, Gong J, Liu J, Zhang H.

A systematic review and meta-analysis of the COVID-19 associated liver injury

Wong YJ, Tan M, Zheng Q, Li W, Kumar R, Fock KM, Teo EK, Ang TL.

Liver Injury in COVID-19 Infection: A Systematic Review

Ghoda A, Ghoda M.

COVID-19 and liver injury: where do we stand?

Papadopoulos N, Vasileiadi S, Deutsch M.

Clinical characteristics of coronavirus disease 2019 patients complicated with liver injury

Wen M, Lu J, Xie Y.

Rationale for using a C-arm fluoroscope to deliver a kilovoltage radiotherapy treatment to COVID-19 patients

Roa D, Moyses H, Leon S, Hamrick B, Sarria GR, Li B, Tajima T, Necas A, Guzman C, Paucar O, Gonzales A, Challco R, Montoya M, Arqque Z, Gonzales A, Hernandez J.

Elevated Liver Enzymes in Patients with COVID-19: Look, but Not Too Hard

Moon AM, Barritt AS 4th.

Systemic inflammation as fuel for acute liver injury in COVID-19

Effenberger M, Grander C, Grabherr F, Griesmacher A, Ploner T, Hartig F, Bellmann-Weiler R, Joannidis M, Zoller H, Weiss G, Adolph TE, Tilg H.

Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study

Webb GJ, Marjot T, Cook JA, Aloman C, Armstrong MJ, Brenner EJ, Catana MA, Cargill T, Dhanasekaran R, García-Juárez I, Hagström H, Kennedy JM, Marshall A, Masson S, Mercer CJ, Perumalswami PV, Ruiz I, Thaker S, Ufere NN, Barnes E, Barritt AS 4th, Moon AM.

COVID-19 and Liver Injury: A Systematic Review and Meta-Analysis

Ahmed J, Rizwan T, Malik F, Akhter R, Malik M, Ahmad J, Khan AW, Chaudhary MA, Usman MS.

Carrying on with liver transplantation during the COVID-19 emergency: Report from piedmont region

Saracco M, Martini S, Tandoi F, Dell'Olio D, Ottobrelli A, Scarmozzino A, Amoroso A, Fonio P, Balagna R, Romagnoli R.

SARS-CoV-2 another kind of liver aggressor, how does it do that?

Lozano-Sepulveda SA, Galan-Huerta K, Martínez-Acuña N, Arellanos-Soto D, Rivas-Estilla AM.

Clinical characteristics of chronic liver disease with coronavirus disease 2019 (COVID-19): a cohort study in Wuhan, China

Li C, Chen Q, Wang J, Lin H, Lin Y, Lin J, Peng F, Chen J, Yang Z.

Hepatic manifestations of COVID-19

El Ouali S, Romero-Marrero C, Regueiro M.

Optimal multiparametric set-up modelled for best survival outcomes in palliative treatment of liver malignancies: unsupervised machine learning and 3 PM recommendations

Goldstein E, Yeghiazaryan K, Ahmad A, Giordano FA, Fröhlich H, Golubnitschaja O.

Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic

Boettler T, Marjot T, Newsome PN, Mondelli MU, Maticic M, Cordero E, Jalan R, Moreau R, Cornberg M, Berg T.

Gastrointestinal and liver involvement in patients with COVID-19

Barrera FJ, González-González JG, Rodríguez-Gutiérrez R.

Gastrointestinal and liver involvement in patients with COVID-19 - Authors' reply

Qiu Y, He JS, Tan JY, Lin SN, Mao R.

Gastrointestinal and liver involvement in patients with COVID-19

Xu Y, Liu P, Gu J.

Modulating immunosuppression in liver transplant patients with COVID-19

Rodriguez-Peralvarez M, Salcedo M, Colmenero J, Pons JA.

Reply to comment: Screening for active COVID-19 infection prior to biologic therapy in IBD patients: primum non nŏcēre

Zingone F, Buda A, Savarino E.

Clinical insight into the involvement of gut and liver by COVID-19

Abbas Z, Zaheer R.

Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue

Saheb Sharif-Askari N, Saheb Sharif-Askari F, Mdkhana B, Al Heialy S, Ratemi E, Alghamdi M, Abusnana S, Kashour T, Hamid Q, Halwani R.

Trinational Study Exploring the Early Impact of the COVID-19 Pandemic on Organ Donation and Liver Transplantation at National and Unit Levels

Reddy MS, Hakeem AR, Klair T, Marcon F, Mathur A, Samstein B, Mohanka R, Mathur SK, Prachalias A, Menon KV, Muiesan P, Rela M, Emond JC.

Poor outcomes in patients with cirrhosis and Corona Virus Disease-19

Shalimar, Elhence A, Vaishnav M, Kumar R, Pathak P, Soni KD, Aggarwal R, Soneja M, Jorwal P, Kumar A, Khanna P, Singh AK, Biswas A, Nischal N, Dar L, Choudhary A, Rangarajan K, Mohan A, Acharya P, Nayak B, Gunjan D, Saraya A, Mahapatra S, Makharia G, Trikha A, Garg P.

COVID-19 in Liver Transplant Patients: Report of 2 Cases and Review of the Literature

Niknam R, Malek-Hosseini SA, Hashemieh SS, Dehghani M.

Dealing With Liver Transplantation during Coronavirus Disease 2019 Pandemic: Normothermic Machine Perfusion Enables for Donor, Organ, and Recipient Assessment: A Case Report

Bogensperger C, Cardini B, Oberhuber R, Weissenbacher A, Gasteiger S, Berchtold V, Otarashvili G, Öfner D, Schneeberger S.

Liver injury in patients with severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysis

Labenz C, Toenges G, Wörns MA, Sprinzl MF, Galle PR, Schattenberg JM.

Maintaining Patient Safety and Data Integrity of NASH Clinical Trials During the SARS-CoV-2 Pandemic

Alkhouri N, Kohli A, Loomba R, Harrison SA.

Relationship Between COVID-19 Infection and Liver Injury: A Review of Recent Data

Ali N.

Serum Activity of Liver Enzymes Is Associated With Higher Mortality in COVID-19: A Systematic Review and Meta-Analysis

Boregowda U, Aloysius MM, Perisetti A, Gajendran M, Bansal P, Goyal H.

Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data

Lagana SM, Kudose S, Iuga AC, Lee MJ, Fazlollahi L, Remotti HE, Del Portillo A, De Michele S, de Gonzalez AK, Saqi A, Khairallah P, Chong AM, Park H, Uhlemann AC, Lefkowitch JH, Verna EC.

Liver abnormality may develop cerebral venous sinus thrombosis in COVID-19

Neshin SAS, Basirjafari S, Saberi A, Shahhosseini B, Zarei M.

Clinical outcomes of COVID-19 patients with chronic hepatitis B virus infection still need to be explored

Lv XH, Yang JL, Deng K.

Mild vs severe liver injury in SARS-CoV-2 infection

Anastasiou OE, Korth J, Herbstreit F, Witzke O, Lange CM.

Impact of COVID-19 on global hepatitis C elimination efforts

Blach S, Kondili LA, Aghemo A, Cai Z, Dugan E, Estes C, Gamkrelidze I, Ma S, Pawlotsky JM, Razavi-Shearer D, Razavi H, Waked I, Zeuzem S, Craxi A.

Significance of liver dysfunction associated with decreased hepatic CT attenuation values in Japanese patients with severe COVID-19

Uchida Y, Uemura H, Yamaba S, Hamada D, Tarumoto N, Maesaki S, Mochida S.

Hepatology in the COVID Era: Another C Virus, again Challenging the Liver

Peixe P, Calinas F, Tato Marinho R.

In-Person Outreach and Telemedicine in Liver and Intestinal Transplant: A Survey of National Practices, Impact of COVID-19 and Areas of Opportunity

Sherman CB, Said A, Kriss M, Potluri V, Levitsky J, Reese PP, Shea JA, Serper M.

Authors' reply on HIGH RATES OF 30-DAY MORTALITY IN PATIENTS WITH CIRRHOSIS AND COVID-19

Iavarone M, D'Ambrosio R, Lampertico P; CirCoV study group.

Liver transplantation and COVID-19: a case report and cross comparison between two identical twins with COVID-19

Nikoupour H, Arasteh P, Gholami S, Nikeghbalian S.

Abnormal liver-related biomarkers in COVID-19 patients and the role of prealbumin

Li T, Guo Y, Zhuang X, Huang L, Zhang X, Wei F, Yang B.

Letter to the Editors: Statins and COVID-19: Efficacy Still to Be Proven

Meunier L, Meszaros M, Pageaux GP.

Letter to the Editors: COVID-19-Related Liver Injury: The Interpretation for Aspartate Aminotransferase Needs to Be Cautious

Lv XH, Yang JL, Deng K.

In reply to Drs. Lv, Yang, and Deng

Bloom PP, Chung RT.

Liver function should be monitored when treating COVID-19 in chronic HBV-infected patients

Zou X, Fang M, Huang J.

Longitudinal Changes of Liver Function and Hepatitis B Reactivation in COVID-19 Patients with Pre-existing Chronic HBV Infection

Liu J, Wang T, Cai Q, Sun L, Huang D, Zhou G, He Q, Wang FS, Liu L, Chen J.

Comparison of virus concentration methods for the RT-qPCR-based recovery of murine hepatitis virus, a surrogate for SARS-CoV-2 from untreated wastewater

Ahmed W, Bertsch PM, Bivins A, Bibby K, Farkas K, Gathercole A, Haramoto E, Gyawali P, Korajkic A, McMinn BR, Mueller JF, Simpson SL, Smith WJM, Symonds EM, Thomas KV, Verhagen R, Kitajima M.

How Patients With Chronic Liver Diseases Succeed to Deal With COVID-19?

Rezasoltani S, Hatami B, Yadegar A, Asadzadeh Aghdaei H, Zali MR.

Liver injury in COVID-19: What do we know now?

Yang HY, Jin B, Mao YL.

Epidemiological pattern, incidence and outcomes of COVID-19 in liver transplant patients

Colmenero J, Rodríguez-Perálvarez M, Salcedo M, Arias-Milla A, Muñoz-Serrano A, Graus J, Nuño J, Gastaca M, Bustamante-Schneider J, Cachero A, Lladó L, Caballero A, Fernández-Yunquera A, Loinaz C, Fernández I, Fondevilla C, Navasa M, Iñarrairaegui M, Castells L, Pascual S, Ramírez P, Vinaixa C, González-Dieguez ML, González-Grande R, Hierro L, Nogueras F, Otero A, Álamo JM, Blanco-Fernández G, Fábrega E, García-Pajares F, Montero JL, Tomé S, De la Rosa G, Pons JA.

[Guidance on the special care of liver or kidney transplant recipients diagnosed with COVID-19]

Remport Á, Gerlei Z, Cseprekál O, Wagner L, Földes K, Marton A, Patonai A, Török S, Haboub-Sandil A, Varga M, Doros A, Smudla A, Fazakas J, Kóbori L.

How endoscopy centers prepare to reopen after the acute COVID-19 pandemic interruption of activity

Castagna V, Armellini E, Pace F; Fast Track Endoscopy Study Group.

Profiles of liver function abnormalities in elderly patients with Coronavirus Disease 2019

Yu X, He W, Wang L, Bao M, Liu H, Zhou J, Jiang H.

Severe COVID-19 patients with liver injury: a seven-case series

Li X, Zhang ZC, Zhang PL.

Noninvasive monitoring of inflammatory bowel disease in the post COVID-19 era

Nardone OM, Rispo A, Castiglione F.

Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation

Verna EC, Serper M, Chu J, Corey K, Fix OK, Hoyt K, Page KA, Loomba R, Li M, Everson GT, Fried MW, Garcia-Tsao G, Terrault N, Lok AS, Chung RT, Reddy KR.

COVID-19 Lockdown: Impact on Liver Transplant Recipients- A Single Centre Survey

Jothimani D, Daniel H, Danielraj S, Ramachandran H, Rela M.

Prevalence of Abnormal Liver Function Tests in COVID-19 Patients at a Tertiary Care Centre

Kaushik A, Wani SN, Baba MA, Agarwal AK.

Effect of COVID-19 on patients with compensated chronic liver diseases

Ji D, Zhang D, Yang T, Mu J, Zhao P, Xu J, Li C, Cheng G, Wang Y, Chen Z, Qin E, Lau G.

Strengthening vaccine confidence during the COVID-19 pandemic: A new opportunity for global hepatitis B virus elimination

Lazarus JV, Picchio CA, Nayagam S, Ratzan S, Thursz M.

The Antiviral Properties of Cyclosporine. Focus on Coronavirus, Hepatitis C Virus, Influenza Virus, and Human Immunodeficiency Virus Infections

Glowacka P, Rudnicka L, Warszawik-Hendzel O, Sikora M, Goldust M, Gajda P, Stochmal A, Blicharz L, Rakowska A, Olszewska M.

Estimating Shortages in Capacity to Deliver Continuous Kidney Replacement Therapy During the COVID-19 Pandemic in the United States

Reddy YNV, Walensky RP, Mendu ML, Green N, Reddy KP.

Eliminating viral hepatitis in the COVID-19 era: weighing challenge and opportunity

The Lancet Gastroenterology Hepatology.

The impact of COVID-19 on hepatitis elimination

Wingrove C, Ferrier L, James C, Wang S.

Time-dependent changes in the seroprevalence of COVID-19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID-19

Suda G, Ogawa K, Kimura M, Maehara O, Kitagataya T, Ohara M, Tokuchi Y, Kubo A, Yamada R, Shigesawa T, Suzuki K, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Sakamoto N.

Hepatology Consultants Often Disagree on Etiology of Abnormal Liver Biochemistries in COVID-19 but Agree on Management

Bloom PP, Pasricha TS, Andersson KL, Pratt DS, Hashemi N, Bhan I, Viveiros K.

COVID-19 and liver disease: An update

Téllez L, Martín Mateos RM.

Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1827 Patients in a Major U.S. Hospital Network

Hundt MA, Deng Y, Ciarleglio MM, Nathanson MH, Lim JK.

Liver injury in remdesivir-treated COVID-19 patients

Zampino R, Mele F, Florio LL, Bertolino L, Andini R, Galdo M, De Rosa R, Corcione A, Durante-Mangoni E.

Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis

Kovalic AJ, Satapathy SK, Thuluvath PJ.

COVID-19 induced liver function abnormality associates with age

Li S, Li J, Zhang Z, Tan L, Shao T, Li M, Li X, Holmes JA, Lin W, Han M.

Hepatic disorders with the use of remdesivir for coronavirus 2019 (COVID-19)

Montastruc F, Thuriot S, Durrieu G.

Collateral Effect of COVID-19 Pandemic on Hospitalizations and Clinical Outcomes in Gastrointestinal and Liver Diseases - A Territory-wide Observational Study in Hong Kong

Lau LH, Wong SH, Yip TC, Wong GL, Wong VW, Sung JJ.

Hepatitis A susceptibility parallels high COVID-19 mortality

SarialİoĞlu F, Belen FB, Hayran KM.

Digestive and Liver Diseases and the COVID-19 Pandemic

de Franchis R.

Liver damage at admission is an independent prognostic factor for COVID-19

Chen LY, Chu HK, Bai T, Tu SJ, Wei Y, Li ZL, Hu LL, Zhu R, Zhang L, Han CQ, Xiao L, He Q, Song J, Liu WH, Zhu QJ, Chen H, Yang L, Hou XH.

Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis

Wu Y, Li H, Guo X, Yoshida EM, Mendez-Sanchez N, Levi Sandri GB, Teschke R, Romeiro FG, Shukla A, Qi X.

The impact of COVID policies on the vitreoretinal service in St Paul's Eye Unit, Liverpool

Dervenis N, Heimann H, Hussain RN, Chua PY, Sandinha T, Vilà N, Pearce I, Groenewald C, Tan SZ.

Assessing the impact of COVID-19 on the management of patients with liver diseases: A national survey by the Italian association for the study of the Liver

Aghemo A, Masarone M, Montagnese S, Petta S, Ponziani FR, Russo FP; Associazione Italiana Studio Fegato (AISF).

Will "Video kill the Radiostar" or is zooming just a pandemic transient Hype? Some cautionary notes

Macedo G.

SARS-CoV-2 infection in severe pediatric Crohn's disease. What about anti-tumor necrosis factor α therapy?

Giulia B, Patrizia A.

Insights in the approach of long-term liver transplant recipients with COVID-19

Terrabuio DRB, Haddad L, Ducatti L, Gouveia L, Rocha-Santos V, Ferreira RMT, Darce GF, Cardoso AJA, Carrilho FJ, Andraus W, Abdala E, D Albuquerque LAC.

Abnormal liver function tests in COVID-19 patients: relevance and potential pathogenesis

Bertolini A, van de Peppel IP, Bodewes FAJA, Moshage H, Fantin A, Farinati F, Fiorotto R, Jonker JW, Strazzabosco M, Verkade HJ, Peserico G.

The association between markers of liver injury and clinical outcomes in patients with COVID-19 in Wuhan

Huang H, Chen S, Li H, Zhou XL, Dai Y, Jia W, Zhang J, Shao L, Yan R, Wang M, Wang J, Tu Y, Ge M.

Elevated Liver Biochemistries in Hospitalized Chinese Patients with Severe COVID-19: Systematic Review and Meta-analysis

Kovalic AJ, Huang G, Thuluvath PJ, Satapathy SK.

Diagnostic challenges of incidental lung lesions on liver MRI during the COVID-19 pandemic

Deen SS, Wetscherek M, Karia S, Godfrey EM.

Reorganization of the functional gastrointestinal disorders unit during the SARS-CoV-2 outbreak - Practical Recommendations

Ghisa M, Barberio B, Lorenzon G, Zingone F, Savarino E.

Children and Fecal SARS-CoV-2 shedding: Just the tip of the Iceberg of Italian COVID-19 outbreak?

Oliva S, Cucchiara S, Locatelli F.

Higher frequency of hepatic steatosis at CT among COVID-19-positive patients

Medeiros AK, Barbisan CC, Cruz IR, de Ara√∫jo EM, Lib√¢nio BB, Albuquerque KS, Torres US.

Acute on Chronic Liver Failure - Possibly the main culprit of increased mortality in COVID-19 patients with liver disease

Khan MU, Mushtaq K, Alkaabi SR.

Prevalence of functional gastrointestinal disorders in children with celiac disease during the COVID-19 lockdown

Nastro FF, Tolone C, Serra MR, Pacella D, Campanozzi A, Strisciuglio C.

Trends in cirrhosis hospitalizations during the COVID-19 pandemic

Gaspar R, Liberal R, Branco CC, Macedo G.

Running out of bullets: the challenging management of acute hepatitis and SARS-COV-2 from the SMatteo COvid19 Registry (SMACORE)

Colaneri M, Valsecchi P, Perotti L, Ludovisi S, Seminari E, Chiara Pieri T, Sacchi P, Bruno R.

Alcohol related liver disease and Covid-19 emergency: interaction between hepatologist and primary care physician

Testino G, Adriani A.

Value-based medicine, a compass to guide health care decisions in the COVID-19 aftermath

Strazzabosco M.

Alteration of Liver Biomarkers in Patients with SARS-CoV-2 (COVID-19)

Gholizadeh P, Safari R, Marofi P, Zeinalzadeh E, Pagliano P, Ganbarov K, Esposito S, Khodadadi E, Yousefi M, Samadi Kafil H.

Involvement of liver in COVID-19: systematic review and meta-analysis

Yadav DK, Singh A, Zhang Q, Bai X, Zhang W, Yadav RK, Singh A, Zhiwei L, Adhikari VP, Liang T.

Liver Transplant Recipients Infected with SARS-CoV-2 in the Early Postoperative Period: Lessons from a Single Center in the Epicenter of the Pandemic

Waisberg DR, Abdala E, Nacif LS, Haddad LB, Ducatti L, Rocha-Santos V, Gouveia LN, Lazari CS, Martino RB, Pinheiro RS, Arantes RM, Terrabuio DR, Malbouisson LM, Galvao FH, Andraus W, Carneiro-D Albuquerque LA.

COVID-19, liver transplant and immunosuppression: allies or foes?

Parente A, Manzia TM, Angelico R, Tirotta F, Muiesan P, Tisone G, Framarino Dei Malatesta M.

Liver stiffness by transient elastography accompanies illness severity in COVID-19

Effenberger M, Grander C, Fritsche G, Bellmann-Weiler R, Hartig F, Wildner S, Seiwald S, Adolph TE, Zoller H, Weiss G, Tilg H.

Awareness And Concerns About Novel Coronavirus Disease 2019 (COVID-19) Among Parents Of Pediatric Liver Transplant Recipients

Menon J, Shanmugam N, Patel K, Hakeem A, Srinivas Reddy M, Rela M.

Safety, pharmacokinetics, and activity of high-dose ivermectin and chloroquine against the liver-stage of Plasmodium cynomolgi infection in Rhesus Macaques

Vanachayangkul P, Im-Erbsin R, Tungtaeng A, Kodchakorn C, Roth A, Adams J, Chaisatit C, Saingam P, Sciotti RJ, Reichard GA, Nolan CK, Pybus BS, Black CC, Lugo-Roman LA, Wegner MD, Smith PL, Wojnarski M, Vesely BA, Kobylinski KC.

Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort

Bajaj JS, Garcia-Tsao G, Biggins S, Kamath PS, Wong F, McGeorge S, Shaw J, Pearson M, Chew M, Fagan A, de la Rosa Rodriguez R, Worthington J, Olofson A, Weir V, Trisolini C, Dwyer S, Reddy KR.

[Research progress on the clinical features and mechanisms of COVID-19 combined with liver injury]

Xie YB, Wang SY, Zhang C, Wang FS.

The Impacts of the COVID-19 Pandemic on Liver Transplant Patients; Time to Change the Priorities

Dooghaie Moghadam A, Eslami P, Razavi-Khorasani N, Moazzami B, Mousavizadeh M, Zali MR, Sadeghi A.

Letter: liver disease and COVID-19-not the perfect storm. Authors' reply"

Garrido I, Liberal R, Macedo G.

Letter: liver disease and COVID-19-not the perfect storm

Nathwani R, Mukherjee S, Forlano R, Mullish BH, Vergis N, Selvapatt N, Manousou P, Nayagam S, Lemoine M, Dhar A.

Roadmap to Resuming Care for Liver Diseases after COVID-19

Kapuria D, Bollipo S, Rabiee A, Ben Yakov G, Kumar G, Siau K, Lee HW, Congly S, Turnes J, Dhanasekaran R, Lui RN; Global Online Alliance for Liver Studies (GOAL).

Liver Injury in Critically Ill and Non-critically Ill COVID-19 Patients: A Multicenter, Retrospective, Observational Study

Jiang S, Wang R, Li L, Hong D, Ru R, Rao Y, Miao J, Chen N, Wu X, Ye Z, Hu Y, Xie M, Zuo M, Lu X, Qiu Y, Liang T.

The Impact of COVID-19 Global Pandemic on Morbidity and Mortality of Liver Transplant Recipients Children and Adults: A Systematic Review of Case Series

Gavriilidis P, Pai M.

Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations

Sonzogni A, Previtali G, Seghezzi M, Alessio MG, Gianatti A, Licini L, Morotti D, Zerbi P, Carsana L, Rossi R, Laur E, Pellegrinelli A, Nebuloni M.

"Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient"

Reiberger T, Mandorfer M.

Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic

Mehta N, Parikh N, Kelley RK, Hameed B, Singal AG.

Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy

Lenti MV, Borrelli de Andreis F, Pellegrino I, Klersy C, Merli S, Miceli E, Aronico N, Mengoli C, Di Stefano M, Cococcia S, Santacroce G, Soriano S, Melazzini F, Delliponti M, Baldanti F, Triarico A, Corazza GR, Pinzani M, Di Sabatino A; Internal Medicine Covid-19 Team.

COVID-19 and liver transplantation

Di Maira T, Berenguer M.

Successful urgent liver transplant due to fulminant autoimmune hepatitis during the height of the COVID-19 pandemic in Spain

Rodríguez-Gandía MA, López-Hervás P, Téllez L, Gajate L; en nombre de la Unidad de Trasplante Hepático.

Suspension of ulipristal acetate for uterine fibroids during ongoing EMA's review of liver injury risk: Unfortunate timing during the Covid-19 pandemic!

Rozenberg S, Revercez P, Fastrez M, Vandromme J, Bucella D.

Liver injury in severe COVID-19 infection: current insights and challenges

Ali N, Hossain K.

Patients with COVID-19 present with low plasma citrulline concentrations that associate with systemic inflammation and gastrointestinal symptoms

Uzzan M, Soudan D, Peoch K, Weiss E, Corcos O, Treton X.

Unchanged surgical management of patients with Cholangiocarcinoma during the COVID-19 pandemic

Gringeri E, Gambato M, Furlanetto A, Ballo M, Nieddu E, Cillo U.

Liver transplant immunosuppression during the covid-19 pandemic

Forns X, Navasa M.

Inflammasome Activation and Pyroptosis in Lymphopenic COVID-19 Liver Patients

Kroemer A, Khan K, Plassmeyer M, Alpan O, Haseeb MA, Gupta R, Fishbein TM.

Predictor of poor prognosis of COVID-19 patients----liver injury

Fu T, Deng M, Wang X, Yang F.

Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19

Yip TC, Lui GC, Wong VW, Chow VC, Ho TH, Li TC, Tse YK, Hui DS, Chan HL, Wong GL.

Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis

Artru F, Alberio L, Moradpour D, Stalder G.

Prevalence of acute liver injury and hypertransaminemia in patients with COVID-19: a protocol for a systematic review

Li G, Xu Y, Yang YT, Liu PF.

COVID-19-related thrombotic microangiopathy in a cirrhotic patient

Airoldi A, Perricone G, De Nicola S, Molisano C, Tarsia P, Belli LS.

COVID-19 and liver injury: a meta-analysis

Wijarnpreecha K, Ungprasert P, Panjawatanan P, Harnois DM, Zaver HB, Ahmed A, Kim D.

COVID-19: an emergent cause of liver injury?

Cadranel JF, Reboux N, Nousbaum JB.

Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19

Kulkarni AV, Kumar P, Tevethia HV, Premkumar M, Arab JP, Candia R, Talukdar R, Sharma M, Qi X, Rao PN, Reddy DN.

Bilio-pancreatic endoscopy during COVID-19 pandemic

Bove V, Schepis T, Boškoski I, Landi R, Orlandini B, Pontecorvi V, Familiari P, Tringali A, Perri V, Costamagna G.

Who comes first: Rescheduling endoscopic activity after the acute phase of the Covid 19 pandemic

Tripodi G, Dilaghi E, Fanella S, Corleto VD, Giulio ED; Endoscopy prioritization group.

Reply to "Liver tests abnormalities in COVID-19: trick or treat?"

Cai Q, Xu L, Chen J.

Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2 positive patients

Romana Ponziani F, Del Zompo F, Nesci A, Santopaolo F, Ianiro G, Pompili M, Gasbarrini A; “Gemelli against COVID-19” group.

Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis

Kumar-M P, Mishra S, Jha DK, Shukla J, Choudhury A, Mohindra R, Mandavdhare HS, Dutta U, Sharma V.

Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)

Sarin SK, Choudhury A, Lau GK, Zheng MH, Ji D, Abd-Elsalam S, Hwang J, Qi X, Cua IH, Suh JI, Park JG, Putcharoen O, Kaewdech A, Piratvisuth T, Treeprasertsuk S, Park S, Wejnaruemarn S, Payawal DA, Baatarkhuu O, Ahn SH, Yeo CD, Alonzo UR, Chinbayar T, Loho IM, Yokosuka O, Jafri W, Tan S, Soo LI, Tanwandee T, Gani R, Anand L, Esmail ES, Khalaf M, Alam S, Lin CY, Chuang WL, Soin AS, Garg HK, Kalista K, Batsukh B, Purnomo HD, Dara VP, Rathi P, Al Mahtab M, Shukla A, Sharma MK, Omata M; APASL COVID T

Telemedicine Platforms and Their Use in the Coronavirus Disease-19 Era to Deliver Comprehensive Vascular Care

Lin JC, Humphries MD, Shutze WP, Aalami OO, Fischer UM, Hodgson KJ.

A brief review of liver injury in patients with Corona Virus Disease-19 during the pandemic

Farshidpour M, Kim D, Junna S, Merchant J.

Deceased Donor Liver Transplantation in India in the COVID-19 Era: Current Scenario and Future Perspectives

Pahari H, Shellagi N, Nath B.

Pharmacologic management of patients with hepatic and pancreatic diseases that involve immunosuppressive therapies. Positioning within the framework of the SARS-CoV-2 (COVID-19) pandemic

Miranda-Zazueta G, González-Regueiro JA, García-Juárez I, Moctezuma-Velázquez C, López-Díaz FJ, Pérez-González B, Uscanga-Domínguez LF, Peláez-Luna M.

Letter to the Editors: Additional Factors to Consider When Studying Liver Injury Indicators and Mortality in COVID-19 Patients

Liu Y.

Letter to the Editor: COVID-19-Related Liver Injury and Clinical Outcomes: Does It Really Exist?

Philips CA, Ahamed R, Augustine P.

Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study

Hao SR, Zhang SY, Lian JS, Jin X, Ye CY, Cai H, Zhang XL, Hu JH, Zheng L, Zhang YM, Jia HY, Yu GD, Wang XY, Gu JQ, Lu YF, Yu XP, Yu L, Xiang DR, Ye CY, Jin CL, Qiu YQ, Li LJ, Sheng JF, Liang TB, Yang YD.

Fatal COVID-19 in a Patient with End-Stage Liver Disease Wait-Listed for Liver Transplantation: An Evidence-Based Review of COVID-19 Screening Modalities Prior to Transplant

Rhee Y, Chan EL, Eswaran SL, Aloman C, Hertl M, Santos CAQ.

Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis

Bruni A, Garofalo E, Zuccalà V, Currò G, Torti C, Navarra G, De Sarro G, Navalesi P, Longhini F, Ammendola M.

Reduced rate of hospital admissions for liver-related morbidities during the initial COVID-19 outbreak

Eshraghian A, Taghavi A, Nikeghbalian S, Malek-Hosseini SA.

Impact of the SARS-CoV-2 outbreak on pediatric liver transplant recipients residing in Lombardy, Northern Italy

Nicastro E, Di Giorgio A, Zambelli M, Ginammi M, Bravi M, Stroppa P, Casotti V, Palladino R, Colledan M, D'Antiga L.

Reply to Letter to the Editor: COVID-19-Related Liver Injury and Clinical Outcomes: Does It Really Exist?

Lei F, Liu YM, Zhou F, Qin JJ, Huang X, Zhang BH, Li H, Yuan Y.

The New Virtual Reality: How COVID-19 Will Affect the Gastroenterology and Hepatology Fellowship Match

Mallepally N, Bilal M, Hernandez-Barco YG, Simons M, Berzin TM, Oxentenko AS.

Impact of COVID-19 on liver transplantation in Europe: Alert from an early survey of European Liver and Intestine Transplantation Association (ELITA) and European Liver Transplant Registry (ELTR)

Polak WG, Fondevila C, Karam V, Adam R, Baumann U, Germani G, Nadalin S, Taimr P, Toso C, Troisi RI, Zieniewicz K, Belli LS, Duvoux C; European Liver, Intestine Transplant Association (ELITA).

Planning phase two for endoscopic units in Northern Italy after the COVID-19 lockdown: An exit strategy with a lot of critical issues and a few opportunities

Manes G, Repici A, Radaelli F, Bezzio C, Colombo M, Saibeni S.

The forgotten victims of the COVID-19 pandemic

Benites-Goñi H, Alférez-Andía J, Barreda-Bolaños F.

Liver transplantation during the COVID-19 epidemic : recommendations from the Belgian Liver Intestine Transplant Committee (BeLIAC)

Dahlqvist G, Ciccarelli O, Van Vlierberghe H, Berrevoet F, Vanwolleghem T, Ysebaert D, Gustot T, Lucidi V, Delwaide J, Detry O, Delbouille MH, Sokal E, Nevens F, Pirenne J.

Clinical Features of COVID-19-Infected Patients With Elevated Liver Biochemistries: A Multicenter, Retrospective Study

Fu Y, Zhu R, Bai T, Han P, He Q, Jing M, Xiong X, Zhao X, Quan R, Chen C, Zhang Y, Tao M, Yi J, Tian D, Yan W.

Critically ill patients with COVID-19 with ECMO and artificial liver plasma exchange: A retrospective study

Liu J, Dong YQ, Yin J, He G, Wu X, Li J, Qiu Y, He X.

COVID-19 and nonalcoholic fatty liver disease: two intersecting pandemics

Portincasa P, Krawczyk M, Smyk W, Lammert F, Di Ciaula A.

Patterns of liver injury in COVID-19 - a German case series

Schattenberg JM, Labenz C, Wörns MA, Menge P, Weinmann A, Galle PR, Sprinzl MF.

COVID-19 pandemic: Its impact on liver disease and liver transplantation

Sahin TT, Akbulut S, Yilmaz S.

Challenges for Liver Transplantation During Recovery From the COVID-19 Pandemic: Insights and Recommendations

Niriella MA, Siriwardana RC, Perera MTPR, Narasimhan G, Chan SC, Dassanayake AS.

Hepatocellular Type II Fibrinogen Inclusions in a Patient with Severe COVID-19 and Hepatitis

Fraga M, Moradpour D, Artru F, Romailler E, Tschopp J, Schneider A, Chtioui H, Neerman-Arbez M, Casini A, Alberio L, Sempoux C.

Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement

Wong GL, Wong VW, Thompson A, Jia J, Hou J, Lesmana CRA, Susilo A, Tanaka Y, Chan WK, Gane E, Ong-Go AK, Lim SG, Ahn SH, Yu ML, Piratvisuth T, Chan HL; Asia-Pacific Working Group for Liver Derangement during the COVID-19 Pandemic.

Impact of Chronic Liver Disease on Outcomes of Hospitalized Patients with COVID-19: A Multicenter United States Experience

Hashemi N, Viveiros K, Redd WD, Zhou JC, McCarty TR, Bazarbashi AN, Hathorn KE, Wong D, Njie C, Shen L, Chan WW.

Treatment of Hepatocellular Carcinoma (HCC) during the COVID-19 Outbreak: The Working Group Report of JAMTT-HCC

Kudo M, Kurosaki M, Ikeda M, Aikata H, Hiraoka A, Torimura T, Sakamoto N; Japan Association of Molecular Targeted Therapy for HCC (JAMTT-HCC).

Challenges in Abdominal Organ Transplantation During the COVID-19 Pandemic

Esagian SM, Ziogas IA, Giannis D, Hayat MH, Elias N, Tsoulfas G.

Hepatic manifestations and complications of COVID-19: A systematic review and meta-analysis

Kunutsor SK, Laukkanen JA.

The impact of COVID-19 on the clinical outcome of patients with cirrhosis deserves more attention and research

Gao F, Huang ZM.

Is the increased risk for MAFLD patients to develop severe COVID-19 linked to perturbation of the gut-liver axis?

Assante G, Williams R, Youngson NA.

Letter regarding [High rates of 30-day mortality in patients with cirrhosis and COVID-19]

Medhat MA, El Kassas M.

Effect of COVID-19 on liver transplantation in KOREA

Lee JM.

Virtual empathy and liver cancer

Debes JD.

Metabolic associated fatty liver disease is associated with severity of COVID-19

Zhou YJ, Zheng KI, Wang XB, Sun QF, Pan KH, Wang TY, Ma HL, Chen YP, George J, Zheng MH.

Clinical epidemiological analyses of overweight/obesity and abnormal liver function contributing to prolonged hospitalization in patients infected with COVID-19

Hu X, Pan X, Zhou W, Gu X, Shen F, Yang B, Hu Z.

Risk factors in patients with COVID-19 developing severe liver injury during hospitalisation

Zhan K, Liao S, Li J, Bai Y, Lv L, Yu K, Qiu L, Li C, Yuan G, Zhang A, Mei Z.

COVID-19 in an international European liver transplant recipient cohort

Becchetti C, Zambelli MF, Pasulo L, Donato MF, Invernizzi F, Detry O, Dahlqvist G, Ciccarelli O, Morelli MC, Fraga M, Svegliati-Baroni G, van Vlierberghe H, Coenraad MJ, Romero MC, de Gottardi A, Toniutto P, Del Prete L, Abbati C, Samuel D, Pirenne J, Nevens F, Dufour JF; COVID-LT group.

Returning to digestive endoscopy normality will be slow and must include novelty and telemedicine

Koulaouzidis A, Marlicz W, Wenzek H, Koulaouzidis G, Eliakim R, Toth E.

COVID-19 with acute cholecystitis: a case report

Ying M, Lu B, Pan J, Lu G, Zhou S, Wang D, Li L, Shen J, Shu J; From the COVID-19 Investigating and Research Team.

Management of liver diseases during the pandemic of coronavirus disease-19

Cho JY, Kim SS, Lee YS, Song DS, Lee JH, Kim JH; Korean Association for the Study of the Liver.

Characteristics of pregnant COVID-19 patients with liver injury

Deng G, Zeng F, Zhang L, Chen H, Chen X, Yin M.